Cover Page
Cover Page - shares | 3 Months Ended | |
Mar. 31, 2021 | May 03, 2021 | |
Cover [Abstract] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Mar. 31, 2021 | |
Document Transition Report | false | |
Entity File Number | 001-36157 | |
Entity Registrant Name | ESSENT GROUP LTD. | |
Entity Incorporation, State or Country Code | D0 | |
Entity Address, Address Line One | Clarendon House | |
Entity Address, Address Line Two | 2 Church Street | |
Entity Address, City or Town | Hamilton | |
Entity Address, Postal Zip Code | HM11 | |
Entity Address, Country | BM | |
City Area Code | 441 | |
Local Phone Number | 297-9901 | |
Title of 12(b) Security | Common Shares, $0.015 par value | |
Trading Symbol | ESNT | |
Security Exchange Name | NYSE | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Large Accelerated Filer | |
Entity Small Business | false | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 112,850,813 | |
Entity Central Index Key | 0001448893 | |
Amendment Flag | false | |
Current Fiscal Year End Date | --12-31 | |
Document Fiscal Year Focus | 2021 | |
Document Fiscal Period Focus | Q1 |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands | Mar. 31, 2021 | Dec. 31, 2020 |
Investments | ||
Total investments available for sale | $ 4,701,476 | $ 4,565,373 |
Other invested assets | 100,393 | 88,904 |
Total investments | 4,801,869 | 4,654,277 |
Cash | 81,022 | 102,830 |
Accrued investment income | 23,600 | 19,948 |
Accounts receivable | 45,618 | 50,140 |
Deferred policy acquisition costs | 14,723 | 17,005 |
Property and equipment (at cost, less accumulated depreciation of $61,830 in 2021 and $60,967 in 2020) | 14,258 | 15,095 |
Prepaid federal income tax | 302,636 | 302,636 |
Other assets | 48,120 | 40,793 |
Total assets | 5,331,846 | 5,202,724 |
Liabilities | ||
Reserve for losses and LAE | 411,123 | 374,941 |
Unearned premium reserve | 235,730 | 250,436 |
Net deferred tax liability | 318,622 | 305,109 |
Credit facility borrowings (at carrying value, less unamortized deferred costs of $2,982 in 2021 and $3,280 in 2020) | 322,018 | 321,720 |
Other accrued liabilities | 123,416 | 87,885 |
Total liabilities | 1,410,909 | 1,340,091 |
Commitments and contingencies (see Note 7) | ||
Stockholders’ Equity | ||
Common shares, $0.015 par value: Authorized - 233,333; issued and outstanding - 112,847 shares in 2021 and 112,423 shares in 2020 | 1,693 | 1,686 |
Additional paid-in capital | 1,571,134 | 1,571,163 |
Accumulated other comprehensive income | 79,071 | 138,274 |
Retained earnings | 2,269,039 | 2,151,510 |
Total stockholders’ equity | 3,920,937 | 3,862,633 |
Total liabilities and stockholders’ equity | 5,331,846 | 5,202,724 |
Fixed maturities available for sale, at fair value (amortized cost: 2021 — $4,167,570; 2020 — $3,677,815) | ||
Investments | ||
Total investments available for sale | 4,252,144 | 3,838,513 |
Short-term investments available for sale, at fair value (amortized cost: 2021 — $449,328; 2020 — $726,875) | ||
Investments | ||
Total investments available for sale | $ 449,332 | $ 726,860 |
Condensed Consolidated Balanc_2
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) shares in Thousands, $ in Thousands | Mar. 31, 2021 | Dec. 31, 2020 |
Investment available for sale | ||
Amortized cost | $ 4,616,898 | $ 4,404,690 |
Property and equipment | ||
Accumulated depreciation | 61,830 | 60,967 |
Credit facility borrowings | ||
Unamortized deferred costs | $ 2,982 | $ 3,280 |
Stockholders’ equity | ||
Common shares, par value (in dollars per share) | $ 0.015 | $ 0.015 |
Common shares, authorized (in shares) | 233,333 | 233,333 |
Common shares, issued (in shares) | 112,847 | 112,423 |
Common shares, outstanding (in shares) | 112,847 | 112,423 |
Fixed maturities | ||
Investment available for sale | ||
Amortized cost | $ 4,167,570 | $ 3,677,815 |
Short-term investments | ||
Investment available for sale | ||
Amortized cost | $ 449,328 | $ 726,875 |
Condensed Consolidated Statemen
Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2020 | |
Revenues: | ||
Net premiums written | $ 204,361 | $ 191,743 |
Decrease in unearned premiums | 14,706 | 14,753 |
Net premiums earned | 219,067 | 206,496 |
Net investment income | 21,788 | 20,633 |
Realized investment gains, net | 641 | 3,135 |
Other income (loss) | 3,301 | (1,424) |
Total revenues | 244,797 | 228,840 |
Losses and expenses: | ||
Provision for losses and LAE | 32,322 | 8,063 |
Other underwriting and operating expenses | 42,239 | 41,947 |
Interest expense | 2,051 | 2,132 |
Total losses and expenses | 76,612 | 52,142 |
Income before income taxes | 168,185 | 176,698 |
Income tax expense | 32,537 | 27,175 |
Net income | $ 135,648 | $ 149,523 |
Earnings per share: | ||
Basic (in dollars per share) | $ 1.21 | $ 1.53 |
Diluted (in dollars per share) | $ 1.21 | $ 1.52 |
Weighted average shares outstanding: | ||
Basic (in shares) | 112,016 | 97,949 |
Diluted (in shares) | 112,378 | 98,326 |
Net income | $ 135,648 | $ 149,523 |
Other comprehensive income (loss): | ||
Change in unrealized depreciation of investments, net of tax benefit of $(10,201) and $(6,979) in the three months ended March 31, 2021 and 2020 | (59,203) | (10,074) |
Total other comprehensive loss | (59,203) | (10,074) |
Comprehensive income | $ 76,445 | $ 139,449 |
Condensed Consolidated Statem_2
Condensed Consolidated Statements of Comprehensive Income (Unaudited) (Parenthetical) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2020 | |
Statement of Comprehensive Income [Abstract] | ||
Change in unrealized appreciation (depreciation) of investments, tax expense (benefit) | $ (10,201) | $ (6,979) |
Condensed Consolidated Statem_3
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($) $ in Thousands | Total | Common Shares | Additional Paid-In Capital | Accumulated Other Comprehensive Income (Loss) | Retained Earnings | Treasury Stock |
Stockholders equity, beginning of period at Dec. 31, 2019 | $ 1,476 | $ 1,118,655 | $ 56,187 | $ 1,808,527 | $ 0 | |
Changes in Stockholders' Equity | ||||||
Net income | $ 149,523 | 149,523 | ||||
Dividends and dividend equivalents declared | 160 | (15,854) | ||||
Issuance of management incentive shares | 5 | (5) | ||||
Stock-based compensation expense | 4,780 | |||||
Treasury stock acquired | (6,306) | |||||
Cancellation of treasury stock | (2) | (6,304) | 6,306 | |||
Other comprehensive loss | (10,074) | (10,074) | ||||
Stockholders equity, end of period at Mar. 31, 2020 | 3,107,074 | 1,479 | 1,117,286 | 46,113 | 1,942,196 | 0 |
Stockholders equity, beginning of period at Dec. 31, 2020 | 3,862,633 | 1,686 | 1,571,163 | 138,274 | 2,151,510 | 0 |
Changes in Stockholders' Equity | ||||||
Net income | 135,648 | 135,648 | ||||
Dividends and dividend equivalents declared | 176 | (18,119) | ||||
Issuance of management incentive shares | 8 | (8) | ||||
Stock-based compensation expense | 5,179 | |||||
Treasury stock acquired | (5,377) | |||||
Cancellation of treasury stock | (1) | (5,376) | 5,377 | |||
Other comprehensive loss | (59,203) | (59,203) | ||||
Stockholders equity, end of period at Mar. 31, 2021 | $ 3,920,937 | $ 1,693 | $ 1,571,134 | $ 79,071 | $ 2,269,039 | $ 0 |
Condensed Consolidated Statem_4
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2020 | |
Operating Activities | ||
Net income | $ 135,648 | $ 149,523 |
Adjustments to reconcile net income to net cash provided by operating activities: | ||
Gain on the sale of investments, net | (641) | (3,135) |
Equity in net (income) loss of other invested assets | (526) | 96 |
Distribution of income from other invested assets | 428 | 339 |
Depreciation and amortization | 863 | 878 |
Stock-based compensation expense | 5,179 | 4,780 |
Amortization of premium on investment securities | 6,468 | 5,840 |
Deferred income tax provision | 23,714 | 17,047 |
Change in: | ||
Accrued investment income | (3,652) | (37) |
Accounts receivable | 3,867 | 805 |
Deferred policy acquisition costs | 2,282 | 558 |
Other assets | (6,874) | (2,877) |
Reserve for losses and LAE | 36,182 | 3,979 |
Unearned premium reserve | (14,706) | (14,753) |
Other accrued liabilities | (461) | 88 |
Net cash provided by operating activities | 187,771 | 163,131 |
Investing Activities | ||
Net change in short-term investments | 277,528 | (279,803) |
Purchase of investments available for sale | (681,516) | (294,746) |
Proceeds from maturity of investments available for sale | 56,603 | 29,472 |
Proceeds from sales of investments available for sale | 166,390 | 159,127 |
Purchase of other invested assets | (11,150) | (2,310) |
Return of investment from other invested assets | 6,460 | 7,300 |
Purchase of property and equipment | (574) | (466) |
Net cash used in investing activities | (186,259) | (381,426) |
Financing Activities | ||
Credit facility borrowings | 0 | 200,000 |
Treasury stock acquired | (5,377) | (6,306) |
Dividends paid | (17,943) | (15,694) |
Net cash (used in) provided by financing activities | (23,320) | 178,000 |
Net decrease in cash | (21,808) | (40,295) |
Cash at beginning of year | 102,830 | 71,350 |
Cash at end of period | 81,022 | 31,055 |
Supplemental Disclosure of Cash Flow Information | ||
Interest payments | $ (1,762) | $ (1,641) |
Nature of Operations and Basis
Nature of Operations and Basis of Presentation | 3 Months Ended |
Mar. 31, 2021 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Nature of Operations and Basis of Presentation | Nature of Operations and Basis of Presentation Essent Group Ltd. (“Essent Group”) is a Bermuda-based holding company, which, through its wholly-owned subsidiaries, offers private mortgage insurance and reinsurance for mortgages secured by residential properties located in the United States. Mortgage insurance facilitates the sale of low down payment (generally less than 20%) mortgage loans into the secondary mortgage market, primarily to two government-sponsored enterprises (“GSEs”), Fannie Mae and Freddie Mac. The primary mortgage insurance operations are conducted through Essent Guaranty, Inc. (“Essent Guaranty”), a wholly-owned subsidiary approved as a qualified mortgage insurer by the GSEs and is licensed to write mortgage insurance in all 50 states and the District of Columbia. Essent Guaranty reinsures 25% of new insurance written ("NIW") to Essent Reinsurance Ltd. (“Essent Re”), an affiliated Bermuda domiciled Class 3A Insurer licensed pursuant to Section 4 of the Bermuda Insurance Act 1978 that provides insurance and reinsurance coverage of mortgage credit risk. In April 2021, Essent Guaranty and Essent Re agreed to increase the quota share reinsurance coverage of Essent Guaranty’s NIW provided by Essent Re to 35% effective January 1, 2021. The quota share reinsurance coverage provided by Essent Re for Essent Guaranty’s NIW prior to January 1, 2021 will continue to be 25%, the quota share percentage in effect at the time NIW was first ceded. Essent Re also provides insurance and reinsurance to Freddie Mac and Fannie Mae. In 2016, Essent Re formed Essent Agency (Bermuda) Ltd., a wholly-owned subsidiary, which provides underwriting consulting services to third-party reinsurers. In accordance with certain state law requirements then in effect, Essent Guaranty also reinsures that portion of the risk that is in excess of 25% of the mortgage balance with respect to loans insured prior to April 1, 2019, after consideration of other reinsurance, to Essent Guaranty of PA, Inc. (“Essent PA”), an affiliate. In addition to offering mortgage insurance, we provide contract underwriting services on a limited basis through CUW Solutions, LLC ("CUW Solutions"), a Delaware limited liability company, that provides, among other things, mortgage contract underwriting services to lenders and mortgage insurance underwriting services to affiliates. We have prepared the condensed consolidated financial statements included herein pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). We have condensed or omitted certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) pursuant to such rules and regulations. In the opinion of management, the statements include all adjustments (which include normal recurring adjustments) required for a fair statement of financial position, results of operations and cash flows for the interim periods presented. These statements should be read in conjunction with the consolidated financial statements and notes thereto, including Note 1 and Note 2 to the consolidated financial statements, included in our Annual Report on Form 10-K for the year ended December 31, 2020, which discloses the principles of consolidation and a summary of significant accounting policies. The results of operations for the interim periods are not necessarily indicative of the results for the full year. We evaluated the need to recognize or disclose events that occurred subsequent to March 31, 2021 prior to the issuance of these condensed consolidated financial statements. |
Recently Issued Accounting Stan
Recently Issued Accounting Standards | 3 Months Ended |
Mar. 31, 2021 | |
Accounting Policies [Abstract] | |
Recently Issued Accounting Standards | Recently Issued Accounting Standards Accounting Standards Not Yet Adopted In March 2020, the Financial Accounting Standards Board ("FASB") issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting . The amendments in this update provide temporary optional guidance to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform. It provides optional expedients and exceptions for applying generally accepted accounting principles to contract, hedging relationships and other transactions affected by reference rate reform if certain criteria are met. This standard may be elected and applied prospectively over time from March 12, 2020 through December 31, 2022 as reference rate reform activities occur. The adoption of, and future elections under, this ASU are not expected to have a material impact on our consolidated financial statements as the ASU will ease, if warranted, the requirements for accounting for the future effects of the rate reform. We continue to monitor the impact the discontinuance of LIBOR or another reference rate will have on our contracts and other transactions. |
Investments
Investments | 3 Months Ended |
Mar. 31, 2021 | |
Investments, Debt and Equity Securities [Abstract] | |
Investments | Investments Investments available for sale consist of the following: March 31, 2021 (In thousands) Amortized Unrealized Unrealized Fair U.S. Treasury securities $ 257,401 $ 5,854 $ (946) $ 262,309 U.S. agency securities 16,028 110 — 16,138 U.S. agency mortgage-backed securities 1,005,599 24,083 (6,691) 1,022,991 Municipal debt securities (1) 543,742 30,021 (1,500) 572,263 Non-U.S. government securities 77,440 3,818 (1,978) 79,280 Corporate debt securities (2) 1,391,881 38,183 (15,126) 1,414,938 Residential and commercial mortgage securities 439,583 12,379 (5,754) 446,208 Asset-backed securities 471,677 3,000 (873) 473,804 Money market funds 413,547 — (2) 413,545 Total investments available for sale $ 4,616,898 $ 117,448 $ (32,870) $ 4,701,476 December 31, 2020 (In thousands) Amortized Unrealized Unrealized Fair U.S. Treasury securities $ 259,378 $ 9,088 $ (22) $ 268,444 U.S. agency securities 17,930 155 — 18,085 U.S. agency mortgage-backed securities 963,670 33,205 (970) 995,905 Municipal debt securities (1) 513,870 37,662 (15) 551,517 Non-U.S. government securities 56,045 5,562 — 61,607 Corporate debt securities (2) 1,070,027 56,864 (379) 1,126,512 Residential and commercial mortgage securities 391,921 18,641 (1,280) 409,282 Asset-backed securities 452,527 3,246 (1,056) 454,717 Money market funds 679,322 — (18) 679,304 Total investments available for sale $ 4,404,690 $ 164,423 $ (3,740) $ 4,565,373 March 31, December 31, (1) The following table summarizes municipal debt securities as of : 2021 2020 Special revenue bonds 76.9 % 76.8 % General obligation bonds 20.3 20.3 Certificate of participation bonds 2.1 2.3 Tax allocation bonds 0.6 0.6 Special tax bonds 0.1 — Total 100.0 % 100.0 % March 31, December 31, (2) The following table summarizes corporate debt securities as of : 2021 2020 Financial 32.8 % 34.9 % Consumer, non-cyclical 19.2 19.1 Communications 11.6 9.3 Consumer, cyclical 7.6 8.0 Industrial 7.3 5.3 Energy 6.6 8.2 Utilities 5.9 5.9 Technology 5.4 6.1 Basic materials 3.5 3.1 Government 0.1 0.1 Total 100.0 % 100.0 % The amortized cost and fair value of investments available for sale at March 31, 2021, by contractual maturity, are shown below. Expected maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. Because most U.S. agency mortgage-backed securities, residential and commercial mortgage securities and asset-backed securities provide for periodic payments throughout their lives, they are listed below in separate categories. (In thousands) Amortized Fair U.S. Treasury securities: Due in 1 year $ 51,984 $ 52,264 Due after 1 but within 5 years 155,396 158,188 Due after 5 but within 10 years 49,036 50,890 Due after 10 years 985 967 Subtotal 257,401 262,309 U.S. agency securities: Due in 1 year 12,530 12,638 Due after 1 but within 5 years 3,498 3,500 Subtotal 16,028 16,138 Municipal debt securities: Due in 1 year 7,495 7,519 Due after 1 but within 5 years 98,704 103,013 Due after 5 but within 10 years 229,338 243,858 Due after 10 years 208,205 217,873 Subtotal 543,742 572,263 Non-U.S. government securities: Due in 1 year 4,360 4,473 Due after 1 but within 5 years 18,348 19,499 Due after 5 but within 10 years 26,603 29,045 Due after 10 years 28,129 26,263 Subtotal 77,440 79,280 Corporate debt securities: Due in 1 year 147,203 148,503 Due after 1 but within 5 years 648,697 667,465 Due after 5 but within 10 years 378,395 386,311 Due after 10 years 217,586 212,659 Subtotal 1,391,881 1,414,938 U.S. agency mortgage-backed securities 1,005,599 1,022,991 Residential and commercial mortgage securities 439,583 446,208 Asset-backed securities 471,677 473,804 Money market funds 413,547 413,545 Total investments available for sale $ 4,616,898 $ 4,701,476 Gross gains and losses realized on the sale of investments available for sale were as follows: Three Months Ended March 31, (In thousands) 2021 2020 Realized gross gains $ 750 $ 3,262 Realized gross losses 109 127 The fair value of investments available for sale in an unrealized loss position and the related unrealized losses for which no allowance for credit loss has been recorded were as follows: Less than 12 months 12 months or more Total March 31, 2021 (In thousands) Fair Gross Fair Gross Fair Gross U.S. Treasury securities $ 88,240 $ (946) $ — $ — $ 88,240 $ (946) U.S. agency mortgage-backed securities 411,509 (6,667) 1,044 (24) 412,553 (6,691) Municipal debt securities 94,305 (1,500) — — 94,305 (1,500) Non-U.S. government securities 28,820 (1,978) — — 28,820 (1,978) Corporate debt securities 560,659 (15,112) 235 (14) 560,894 (15,126) Residential and commercial mortgage securities 191,043 (5,013) 17,628 (741) 208,671 (5,754) Asset-backed securities 131,675 (630) 39,360 (243) 171,035 (873) Money market funds 22,502 (2) — — 22,502 (2) Total $ 1,528,753 $ (31,848) $ 58,267 $ (1,022) $ 1,587,020 $ (32,870) Less than 12 months 12 months or more Total December 31, 2020 (In thousands) Fair Gross Fair Gross Fair Gross U.S. Treasury securities $ 28,776 $ (22) $ — $ — $ 28,776 $ (22) U.S. agency mortgage-backed securities 152,671 (924) 3,007 (46) 155,678 (970) Municipal debt securities 3,838 (15) — — 3,838 (15) Corporate debt securities 141,803 (379) — — 141,803 (379) Residential and commercial mortgage securities 63,203 (777) 9,516 (503) 72,719 (1,280) Asset-backed securities 124,165 (483) 65,897 (573) 190,062 (1,056) Money market funds 99,995 (18) — — 99,995 (18) Total $ 614,451 $ (2,618) $ 78,420 $ (1,122) $ 692,871 $ (3,740) At March 31, 2021 and December 31, 2020, we held 802 and 363 individual investment securities, respectively, that were in an unrealized loss position. We assess our intent to sell these securities and whether we will be required to sell these securities before the recovery of their amortized cost basis when determining whether to record an impairment on the securities in an unrealized loss position. In assessing whether the decline in the fair value at March 31, 2021 of any of these securities resulted from a credit loss or other factors, we made inquiries of our investment managers to determine that each issuer was current on its scheduled interest and principal payments. We reviewed the credit rating of these securities noting that over 98% of the securities at March 31, 2021 had investment-grade ratings. We concluded that gross unrealized losses noted above are principally associated with the changes in interest rates subsequent to purchase rather than due to credit impairment. There were no impairments in the three months ended March 31, 2021 or March 31, 2020. The Company's other invested assets at March 31, 2021 and December 31, 2020 totaled $100.4 million and $88.9 million, respectively. Other invested assets are comprised of limited partnership interests which are generally accounted for under the equity method of accounting with changes in value reported in other income. Due to the timing of receiving financial information from these partnerships, the results are generally reported on a one month or quarter lag. The fair value of investments deposited with insurance regulatory authorities to meet statutory requirements was $9.4 million at March 31, 2021 and $9.7 million at December 31, 2020. In connection with its insurance and reinsurance activities, Essent Re is required to maintain assets in trusts for the benefit of its contractual counterparties. The fair value of the investments on deposit in these trusts was $1.2 billion at March 31, 2021 and $1.1 billion at December 31, 2020. Essent Guaranty is required to maintain assets on deposit in connection with its fully collateralized reinsurance agreements (see Note 4). The fair value of the assets on deposit was $8.5 million at March 31, 2021 and $8.5 million at December 31, 2020. Essent Guaranty is also required to maintain assets on deposit for the benefit of the sponsor of a fixed income investment commitment. The fair value of the assets on deposit was $12.0 million at March 31, 2021 and $12.0 million at December 31, 2020. Net investment income consists of: Three Months Ended March 31, (In thousands) 2021 2020 Fixed maturities $ 23,024 $ 20,614 Short-term investments 81 1,122 Gross investment income 23,105 21,736 Investment expenses (1,317) (1,103) Net investment income $ 21,788 $ 20,633 |
Reinsurance
Reinsurance | 3 Months Ended |
Mar. 31, 2021 | |
Reinsurance Disclosures [Abstract] | |
Reinsurance | Reinsurance In the ordinary course of business, our insurance subsidiaries may use reinsurance to provide protection against adverse loss experience and to expand our capital sources. Reinsurance recoverables are recorded as assets and included in other assets on our condensed consolidated balance sheets, predicated on a reinsurer's ability to meet their obligations under the reinsurance agreements. If the reinsurers are unable to satisfy their obligations under the agreements, our insurance subsidiaries would be liable for such defaulted amounts. The effect of reinsurance on net premiums written and earned is as follows: Three Months Ended (In thousands) 2021 2020 Net premiums written: Direct $ 235,257 $ 205,980 Ceded (1) (30,896) (14,237) Net premiums written $ 204,361 $ 191,743 Net premiums earned: Direct $ 249,963 $ 220,733 Ceded (1) (30,896) (14,237) Net premiums earned $ 219,067 $ 206,496 (1) Net of profit commission. Quota Share Reinsurance Effective September 1, 2019, Essent Guaranty entered into a quota share reinsurance agreement with a panel of third-party reinsurers (the "QSR Agreement"). Each of the third-party reinsurers has an insurer financial strength rating of A or better by S&P Global Ratings, A.M. Best or both. Under the QSR Agreement, Essent Guaranty will cede premiums earned related to 40% of risk on eligible single premium policies and 20% of risk on all other eligible policies written September 1, 2019 through December 31, 2020, in exchange for reimbursement of ceded claims and claims expenses on covered policies, a 20% ceding commission, and a profit commission of up to 60% that varies directly and inversely with ceded claims. The QSR Agreement is scheduled to terminate on December 31, 2030. Essent Guaranty has certain termination rights under the QSR Agreement, including the option to terminate the QSR Agreement with no termination fee on December 31, 2021, and the option, subject to a termination fee, to terminate the QSR Agreement on December 31, 2022, or annually thereafter. Should Essent Guaranty not exercise its option to terminate the QSR Agreement on December 31, 2021, the maximum profit commission that Essent Guaranty could earn would increase to 63% in 2022 and thereafter. RIF ceded under the QSR Agreement was $5.8 billion as of March 31, 2021. Excess of Loss Reinsurance Essent Guaranty has entered into fully collateralized reinsurance agreements ("Radnor Re Transactions") with unaffiliated special purpose insurers domiciled in Bermuda. For the reinsurance coverage periods, Essent Guaranty and its affiliates retain the first layer of the respective aggregate losses, and a Radnor Re special purpose insurer will then provide second layer coverage up to the outstanding reinsurance coverage amount. Essent Guaranty and its affiliates retain losses in excess of the outstanding reinsurance coverage amount. The reinsurance premium due to each Radnor Re special purpose insurer is calculated by multiplying the outstanding reinsurance coverage amount at the beginning of a period by a coupon rate, which is the sum of one-month LIBOR plus a risk margin, and then subtracting actual investment income collected on the assets in the related reinsurance trust during that period. The aggregate excess of loss reinsurance coverage decreases over a ten-year period as the underlying covered mortgages amortize. Essent Guaranty has rights to terminate the Radnor Re Transactions. The Radnor Re entities collateralized the coverage by issuing mortgage insurance-linked notes ("ILNs") in an aggregate amount equal to the initial coverage to unaffiliated investors. The notes have ten-year legal maturities and are non-recourse to any assets of Essent Guaranty or its affiliates. The proceeds of the notes were deposited into reinsurance trusts for the benefit of Essent Guaranty and will be the source of reinsurance claim payments to Essent Guaranty and principal repayments on the ILNs. Essent Guaranty has also entered into reinsurance agreements with panels of reinsurers that provide aggregate excess of loss coverage immediately above or pari-passu to the coverage provided by the Radnor Re Transactions. The aggregate excess of loss reinsurance coverage decreases over a ten-year period as the underlying covered mortgages amortize. Essent Guaranty has rights to terminate these reinsurance agreements. The following table summarizes Essent Guaranty's excess of loss reinsurance agreements as of March 31, 2021: Vintage Year Reinsurer Effective Date Optional Termination Date 2015 & 2016 Radnor Re 2019-2 Ltd. June 20, 2019 June 25, 2024 2017 Radnor Re 2018-1 Ltd. March 22, 2018 March 25, 2023 (1) 2017 Panel of Reinsurers November 1, 2018 October 1, 2023 (2) 2018 Radnor Re 2019-1 Ltd. February 28, 2019 February 25, 2026 2018 Panel of Reinsurers February 28, 2019 February 25, 2026 2019 Radnor Re 2020-1 Ltd. January 30, 2020 January 25, 2027 2019 Panel of Reinsurers January 30, 2020 January 25, 2027 2019 & 2020 Radnor Re 2020-2 Ltd. October 8, 2020 October 25, 2027 (1) If the reinsurance agreement is not terminated at the optional termination date, the risk margin component of the reinsurance premium increases by 50%. (2) If the reinsurance agreement is not terminated at the optional termination date, the reinsurance premium increases by 50%. The following table summarizes Essent Guaranty's excess of loss reinsurance coverages and retentions as of March 31, 2021: (In thousands) Remaining Vintage Year Remaining Remaining ILN Other Reinsurance Total Remaining 2015 & 2016 $ 13,987,747 $ 3,777,142 $ 216,480 $ — $ 216,480 $ 207,588 2017 13,285,965 3,404,783 242,123 165,167 (5) 407,290 218,262 2018 15,328,438 3,897,423 325,537 76,144 (6) 401,681 250,350 2019 (3) 18,493,963 4,724,213 495,889 55,102 (7) 550,991 215,481 2019 & 2020 (4) 43,365,923 10,872,860 399,159 — 399,159 465,690 Total $ 104,462,036 $ 26,676,421 $ 1,679,188 $ 296,413 $ 1,975,601 $ 1,357,371 (3) Reinsurance coverage on new insurance written from January 1, 2019 through August 31, 2019. (4) Reinsurance coverage on new insurance written from September 1, 2019 through July 31, 2020. (5) Coverage provided immediately above the coverage provided by Radnor Re 2018-1 Ltd. (6) Coverage provided pari-passu to the coverage provided by Radnor Re 2019-1 Ltd. (7) Coverage provided pari-passu to the coverage provided by Radnor Re 2020-1 Ltd. Based on the level of delinquencies reported to us, the ILN transactions entered into prior to March 31, 2020 became subject to a "trigger event" as of June 25, 2020. The amortization of principal of the notes issued by the unaffiliated special purpose insurers in connection with the ILNs is suspended and the aggregate excess of loss reinsurance coverage will not amortize during the continuation of a trigger event. The amount of monthly reinsurance premium ceded to the Radnor Re entities will fluctuate due to changes in one-month LIBOR and changes in money market rates that affect investment income collected on the assets in the reinsurance trusts. As the reinsurance premium will vary based on changes in these rates, we concluded that the Radnor Re Transactions contain embedded derivatives that will be accounted for separately like freestanding derivatives. In connection with the Radnor Re Transactions, we concluded that the risk transfer requirements for reinsurance accounting were met as each Radnor Re entity is assuming significant insurance risk and a reasonable possibility of a significant loss. In addition, we assessed whether each Radnor Re entity was a variable interest entity ("VIE") and the appropriate accounting for the Radnor Re entities if they were VIEs. A VIE is a legal entity that does not have sufficient equity at risk to finance its activities without additional subordinated financial support or is structured such that equity investors lack the ability to make significant decisions relating to the entity’s operations through voting rights or do not substantively participate in the gains and losses of the entity. A VIE is consolidated by its primary beneficiary. The primary beneficiary is the entity that has both (1) the power to direct the activities of the VIE that most significantly affect the entity’s economic performance and (2) the obligation to absorb losses or the right to receive benefits that could be potentially significant to the VIE. While also considering these factors, the consolidation conclusion depends on the breadth of the decision-making ability and ability to influence activities that significantly affect the economic performance of the VIE. We concluded that the Radnor Re entities are VIEs. However, given that Essent Guaranty (1) does not have the unilateral power to direct the activities that most significantly affect their economic performance and (2) does not have the obligation to absorb losses or the right to receive benefits that could be potentially significant to these entities, the Radnor Re entities are not consolidated in these financial statements. The following table presents total assets of each Radnor Re special purpose insurer as well as our maximum exposure to loss associated with each Radnor Re entity, representing the fair value of the embedded derivative, using observable inputs in active markets (Level 2), included in other assets (other accrued liabilities) on our condensed consolidated balance sheet and the estimated net present value of investment earnings on the assets in the reinsurance trust, each as of March 31, 2021: Maximum Exposure to Loss (In thousands) Total VIE Assets On - Balance Sheet Off - Balance Sheet Total Radnor Re 2018-1 Ltd. $ 242,123 $ 367 $ 40 $ 407 Radnor Re 2019-1 Ltd. 325,537 (2,183) 67 (2,116) Radnor Re 2019-2 Ltd. 216,480 (1,603) 31 (1,572) Radnor Re 2020-1 Ltd. 495,889 (1,202) 126 (1,076) Radnor Re 2020-2 Ltd. 399,159 (330) 93 (237) Total $ 1,679,188 $ (4,951) $ 357 $ (4,594) |
Reserve for Losses and Loss Adj
Reserve for Losses and Loss Adjustment Expenses | 3 Months Ended |
Mar. 31, 2021 | |
Liability for Future Policy Benefits and Unpaid Claims and Claims Adjustment Expense [Abstract] | |
Reserve for Losses and Loss Adjustment Expenses | Reserve for Losses and Loss Adjustment Expenses The following table provides a reconciliation of the beginning and ending reserve balances for losses and loss adjustment expenses (“LAE”) for the three months ended March 31: (In thousands) 2021 2020 Reserve for losses and LAE at beginning of period $ 374,941 $ 69,362 Less: Reinsurance recoverables 19,061 71 Net reserve for losses and LAE at beginning of period 355,880 69,291 Add provision for losses and LAE, net of reinsurance, occurring in: Current period 47,989 15,419 Prior years (15,667) (7,356) Net incurred losses and LAE during the current period 32,322 8,063 Deduct payments for losses and LAE, net of reinsurance, occurring in: Current period 114 1 Prior years 1,872 4,110 Net loss and LAE payments during the current period 1,986 4,111 Net reserve for losses and LAE at end of period 386,216 73,243 Plus: Reinsurance recoverables 24,907 98 Reserve for losses and LAE at end of period $ 411,123 $ 73,341 For the three months ended March 31, 2021, $1.9 million was paid for incurred claims and claim adjustment expenses attributable to insured events of prior years. There has been a $15.7 million favorable prior year development during the three months ended March 31, 2021. Reserves remaining as of March 31, 2021 for prior years are $338.3 million as a result of re-estimation of unpaid losses and loss adjustment expenses. For the three months ended March 31, 2020, $4.1 million was paid for incurred claims and claim adjustment expenses attributable to insured events of prior years. There was a $7.4 million favorable prior year development during the three months ended March 31, 2020. Reserves remaining as of March 31, 2020 for prior years were $57.8 million as a result of re-estimation of unpaid losses and loss adjustment expenses. In both periods, the favorable prior years' loss development was the result of a re-estimation of amounts ultimately to be paid on prior year defaults in the default inventory, including the impact of previously identified defaults that cured. Original estimates are increased or decreased as additional information becomes known regarding individual claims. Due to business restrictions, stay-at-home orders and travel restrictions initially implemented in March 2020 as a result of COVID-19, unemployment in the United States increased significantly in the second quarter of 2020 and remained elevated at March 31, 2021. As unemployment is one of the most common reasons for borrowers to default on their mortgage, the increase in unemployment has increased the number of delinquencies on the mortgages that we insure and has the potential to increase claim frequencies on defaults. As of March 31, 2021, insured loans in default totaled 29,080 and included 26,874 |
Debt Obligations
Debt Obligations | 3 Months Ended |
Mar. 31, 2021 | |
Debt Disclosure [Abstract] | |
Debt Obligations | Debt Obligations Credit Facility Essent Group and its subsidiaries, Essent Irish Intermediate Holdings Limited and Essent US Holdings, Inc. (collectively, the "Borrowers"), are parties to a secured credit facility (the “Credit Facility”) with committed capacity of $625 million. The Credit Facility provides for a $300 million revolving credit facility and $325 million of term loans. The Credit Facility also provides an option to increase the capacity to $775 million. Borrowings under the Credit Facility may be used for working capital and general corporate purposes, including, without limitation, capital contributions to Essent’s insurance and reinsurance subsidiaries. Borrowings accrue interest at a floating rate tied to a standard short-term borrowing index, selected at the Company’s option, plus an applicable margin. A commitment fee is due quarterly on the average daily amount of the undrawn revolving commitment. The applicable margin and the commitment fee are based on the senior unsecured debt rating or long-term issuer rating of Essent Group to the extent available, or the insurer financial strength rating of Essent Guaranty. The annual commitment fee rate at March 31, 2021 was 0.35%. The obligations under the Credit Facility are secured by certain assets of the Borrowers, excluding the stock and assets of its insurance and reinsurance subsidiaries. The Credit Facility contains several covenants, including financial covenants relating to minimum net worth, capital and liquidity levels, maximum debt to capitalization level and Essent Guaranty's compliance with the PMIERs (see Note 14). The borrowings under the Credit Facility contractually mature on October 16, 2023. As of March 31, 2021, the Company was in compliance with the covenants and $325 million had been borrowed under the Credit Facility with a weighted average interest rate of 2.13%. As of December 31, 2020, $325 million had been borrowed with a weighted average interest rate of 2.19%. |
Commitments and Contingencies
Commitments and Contingencies | 3 Months Ended |
Mar. 31, 2021 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies Obligations under Guarantees Under the terms of CUW Solutions' contract underwriting agreements with lenders and subject to contractual limitations on liability, we agree to indemnify certain lenders against losses incurred in the event that we make an error in determining whether loans processed meet specified underwriting criteria, to the extent that such error materially restricts or impairs the salability of such loan, results in a material reduction in the value of such loan or results in the lender repurchasing the loan. The indemnification may be in the form of monetary or other remedies. We paid less than $0.1 million related to remedies for each of the three months ended March 31, 2021 and 2020. As of March 31, 2021, management believes any potential claims for indemnification related to contract underwriting services through March 31, 2021 are not material to our consolidated financial position or results of operations. In addition to the indemnifications discussed above, in the normal course of business, we enter into agreements or other relationships with third parties pursuant to which we may be obligated under specified circumstances to indemnify the counterparties with respect to certain matters. Our contractual indemnification obligations typically arise in the context of agreements entered into by us to, among other things, purchase or sell services, finance our business and business transactions, lease real property and license intellectual property. The agreements we enter into in the normal course of business generally require us to pay certain amounts to the other party associated with claims or losses if they result from our breach of the agreement, including the inaccuracy of representations or warranties. The agreements we enter into may also contain other indemnification provisions that obligate us to pay amounts upon the occurrence of certain events, such as the negligence or willful misconduct of our employees, infringement of third-party intellectual property rights or claims that performance of the agreement constitutes a violation of law. Generally, payment by us under an indemnification provision is conditioned upon the other party making a claim, and typically we can challenge the other party’s claims. Further, our indemnification obligations may be limited in time and/or amount, and in some instances, we may have recourse against third parties for certain payments made by us under an indemnification agreement or obligation. As of March 31, 2021, contingencies triggering material indemnification obligations or payments have not occurred historically and are not expected to occur. The nature of the indemnification provisions in the various types of agreements and relationships described above are believed to be low risk and pervasive, and we consider them to have a remote risk of loss or payment. We have not recorded any provisions on the condensed consolidated balance sheets related to indemnifications. |
Capital Stock
Capital Stock | 3 Months Ended |
Mar. 31, 2021 | |
Banking Regulation, Total Capital [Abstract] | |
Capital Stock | Capital Stock Our authorized share capital consists of 233.3 million shares of a single class of common shares. The common shares have no pre-emptive rights or other rights to subscribe for additional shares, and no rights of redemption, conversion or exchange. Under certain circumstances and subject to the provisions of Bermuda law and our bye-laws, we may be required to make an offer to repurchase shares held by members. The common shares rank pari-passu with one another in all respects as to rights of payment and distribution. In general, holders of common shares will have one vote for each common share held by them and will be entitled to vote, on a non-cumulative basis, at all meetings of shareholders. In the event that a shareholder is considered a 9.5% Shareholder under our bye-laws, such shareholder's votes will be reduced by whatever amount is necessary so that after any such reduction the votes of such shareholder will not result in any other person being treated as a 9.5% Shareholder with respect to the vote on such matter. Under these provisions certain shareholders may have their voting rights limited to less than one vote per share, while other shareholders may have voting rights in excess of one vote per share. Dividends The following table presents the amounts declared and paid per common share each quarter: Quarter Ended 2020 March 31 $ 0.16 June 30 0.16 September 30 0.16 December 31 0.16 Total dividends per common share declared and paid $ 0.64 Quarter Ended 2021 March 31 $ 0.16 Total dividends per common share declared and paid $ 0.16 In May 2021, the Board of Directors declared a quarterly cash dividend of $0.17 per common share payable on June 10, 2021, to shareholders of record on June 1, 2021. In May 2021, the Board of Directors approved a share repurchase plan that authorized the Company to repurchase $250 million of its common shares in the open market by the end of 2022. |
Stock-Based Compensation
Stock-Based Compensation | 3 Months Ended |
Mar. 31, 2021 | |
Share-based Payment Arrangement [Abstract] | |
Stock-Based Compensation | Stock-Based Compensation In connection with the IPO in 2013, Essent Group's Board of Directors adopted, and Essent Group's shareholders approved, the Essent Group Ltd. 2013 Long-Term Incentive Plan (the "2013 Plan"), which was effective upon completion of the initial public offering. The types of awards available under the 2013 Plan include nonvested shares, nonvested share units, non- qualified share options, incentive stock options, share appreciation rights, and other share-based or cash-based awards. Nonvested shares and nonvested share units granted under the 2013 Plan have rights to dividends, which entitle holders to the same dividend value per share as holders of common shares in the form of dividend equivalent units ("DEUs"). DEUs are subject to the same vesting and other terms and conditions as the corresponding nonvested shares and nonvested share units. DEUs vest when the underlying shares or share units vest and are forfeited if the underlying share or share units forfeit prior to vesting. The following table summarizes nonvested common share, nonvested common share unit and DEU activity for the three months ended March 31, 2021: Time and Performance- Time-Based Share Units DEUs (Shares in thousands) Number of Weighted Number of Weighted Number of Weighted Dividend Equivalent Units Weighted Outstanding at beginning of year 363 $ 47.09 153 $ 46.34 492 $ 46.59 21 $ 37.66 Granted 281 15.64 93 43.67 87 43.65 4 43.50 Vested (113) 45.02 (77) 45.36 (164) 48.01 (8) 38.14 Forfeited — N/A — N/A (6) 50.43 — 36.11 Outstanding at March 31, 2021 531 $ 30.89 169 $ 45.31 409 $ 45.34 17 $ 38.85 In February 2021, certain members of senior management were granted nonvested common shares under the Essent Group Ltd. 2013 Long-Term Incentive Plan ("2013 Plan") that were subject to time-based and performance-based vesting. The time-based share awards granted in February 2021 vest in three Relative Total Shareholder Return ≤25th percentile 50th percentile ≥75th percentile Three-Year Book 14% "Target" 100 % 150 % 200 % 12% 75 % 125 % 175 % 10% 50 % 100 % 150 % 8% 25 % 75 % 125 % 6% 0 % 50 % 100 % In the event that the compounded annual book value per share growth or the relative total shareholder return falls between the performance levels shown above, the nonvested common shares earned will be determined on a straight-line basis between the respective levels shown. In connection with our incentive program covering bonus awards for performance year 2020, in February 2021, time-based share units were issued to certain employees that vest in three Quoted market prices are used for the valuation of common shares granted that do not contain a market condition under ASC 718. The performance-based share awards granted in February 2021 contain a market condition and were valued based on analysis provided by a third-party valuation firm using a risk neutral simulation taking into effect the vesting conditions of the grant. In February 2021, the performance-based share awards granted in 2019 and 2020 to certain members of senior management were amended to provide that such awards will no longer be subject to the achievement of the compounded annual book value per share growth metrics and will be subject to only service-based vesting. As a result, the unvested shares subject to the amended 2019 and 2020 awards will vest on March 1, 2022 and March 1, 2023, respectively, subject to the continued service requirements and other terms and conditions set forth in the applicable award agreements, without taking into consideration any performance metrics. Incremental compensation expense related to amending these awards of $4.0 million will be recognized over a weighted average period of 1.6 years. The total fair value on the vesting date of nonvested shares, share units or DEUs that vested was $16.0 million and $17.8 million for the three months ended March 31, 2021 and 2020, respectively. As of March 31, 2021, there was $35.1 million of total unrecognized compensation expense related to nonvested shares or share units outstanding at March 31, 2021 and we expect to recognize the expense over a weighted average period of 2.1 years. Employees have the option to tender shares to Essent Group to pay the minimum employee statutory withholding taxes associated with shares upon vesting. Common shares tendered by employees to pay employee withholding taxes totaled 122,033 in the three months ended March 31, 2021. The tendered shares were recorded at cost and included in treasury stock. All treasury stock has been cancelled as of March 31, 2021. Compensation expense, net of forfeitures, and related tax effects recognized in connection with nonvested shares was as follows: Three Months Ended March 31, (In thousands) 2021 2020 Compensation expense $ 5,179 $ 4,780 Income tax benefit 986 918 |
Dividend Restrictions
Dividend Restrictions | 3 Months Ended |
Mar. 31, 2021 | |
Statutory Accounting Practices, Statutory Amount Available for Dividend Payments [Abstract] | |
Dividends Restrictions | Dividends Restrictions Our U.S. insurance subsidiaries are subject to certain capital and dividend rules and regulations as prescribed by jurisdictions in which they are authorized to operate. Under the insurance laws of the Commonwealth of Pennsylvania, Essent Guaranty and Essent PA may pay dividends during any 12-month period in an amount equal to the greater of (i) 10% of the preceding year-end statutory policyholders' surplus or (ii) the preceding year's statutory net income. The Pennsylvania statute also specifies that dividends and other distributions can be paid out of positive unassigned surplus without prior approval. At March 31, 2021, Essent Guaranty had unassigned surplus of approximately $385.9 million. Essent Guaranty did not pay dividends to Essent Group or any intermediate holding companies in the three months ended March 31, 2021 or 2020. As a result of PMIERs guidance issued by the GSEs, effective June 30, 2020 through March 31, 2021, Essent Guaranty is required to obtain GSE written approval before paying a dividend. Essent PA had unassigned surplus of approximately $16.0 million as of March 31, 2021. Essent PA did not pay a dividend in the three months ended March 31, 2021 or 2020. On May 5, 2021, Essent Guaranty paid to its parent, Essent US Holdings, Inc., a $100 million dividend. Essent Re is subject to certain dividend restrictions as prescribed by the Bermuda Monetary Authority and under certain agreements with counterparties. In connection with the quota share reinsurance agreement with Essent Guaranty, Essent Re has agreed to maintain a minimum total equity of $100 million. As of March 31, 2021, Essent Re had total equity of $1.1 billion. At March 31, 2021, our insurance subsidiaries were in compliance with these rules, regulations and agreements. |
Earnings per Share (EPS)
Earnings per Share (EPS) | 3 Months Ended |
Mar. 31, 2021 | |
Earnings Per Share [Abstract] | |
Earnings per Share (EPS) | Earnings per Share (EPS) The following table reconciles the net income and the weighted average common shares outstanding used in the computations of basic and diluted earnings per common share: Three Months Ended (In thousands, except per share amounts) 2021 2020 Net income $ 135,648 $ 149,523 Basic weighted average shares outstanding 112,016 97,949 Dilutive effect of nonvested shares 362 377 Diluted weighted average shares outstanding 112,378 98,326 Basic earnings per share $ 1.21 $ 1.53 Diluted earnings per share $ 1.21 $ 1.52 There were 352,623 and 353,230 antidilutive shares for the three months ended March 31, 2021 and 2020, respectively. The nonvested performance-based share awards are considered contingently issuable for purposes of the EPS calculation. Based on the compounded annual book value per share growth and relative total shareholder return as of March 31, 2021, the 2021 performance-based share awards would be issuable at 100% of target under the terms of the arrangements if March 31, 2021 was the end of the contingency period, which is 50% of the shares issued. Based on the compounded annual book value per share growth as of March 31, 2020, 100% of all performance-based share awards would have been issuable under the terms of the arrangements if March 31, 2020 was the end of the contingency period. |
Accumulated Other Comprehensive
Accumulated Other Comprehensive Income (Loss) | 3 Months Ended |
Mar. 31, 2021 | |
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] | |
Accumulated Other Comprehensive Income (Loss) | Accumulated Other Comprehensive Income (Loss) The following table presents the rollforward of accumulated other comprehensive income (loss) for the three months ended March 31, 2021 and 2020: Three Months Ended March 31, 2021 2020 (In thousands) Before Tax Tax Effect Net of Tax Before Tax Tax Effect Net of Tax Balance at beginning of period $ 168,324 $ (30,050) $ 138,274 $ 69,401 $ (13,214) $ 56,187 Other comprehensive income (loss): Unrealized holding gains (losses) on investments: Unrealized holding losses arising during the period (68,763) 10,201 (58,562) (13,918) 6,403 (7,515) Less: Reclassification adjustment for gains included in net income (1) (641) — (641) (3,135) 576 (2,559) Net unrealized losses on investments (69,404) 10,201 (59,203) (17,053) 6,979 (10,074) Other comprehensive loss (69,404) 10,201 (59,203) (17,053) 6,979 (10,074) Balance at end of period $ 98,920 $ (19,849) $ 79,071 $ 52,348 $ (6,235) $ 46,113 (1) Included in net realized investment gains (losses) on our condensed consolidated statements of comprehensive income. |
Fair Value of Financial Instrum
Fair Value of Financial Instruments | 3 Months Ended |
Mar. 31, 2021 | |
Fair Value Disclosures [Abstract] | |
Fair Value of Financial Instruments | Fair Value of Financial Instruments We carry certain of our financial instruments at fair value. We define fair value as the current amount that would be exchanged to sell an asset or transfer a liability, other than in a forced liquidation. Fair Value Hierarchy ASC No. 820 specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our market assumptions. The level within the fair value hierarchy to measure the financial instrument shall be determined based on the lowest level input that is significant to the fair value measurement. The three levels of the fair value hierarchy are as follows: • Level 1 — Quoted prices for identical instruments in active markets accessible at the measurement date. • Level 2 — Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and valuations in which all significant inputs are observable in active markets. Inputs are observable for substantially the full term of the financial instrument. • Level 3 — Valuations derived from one or more significant inputs that are unobservable. Determination of Fair Value When available, we generally use quoted market prices to determine fair value and classify the financial instrument in Level 1. In cases where quoted market prices for similar financial instruments are available, we utilize these inputs for valuation techniques and classify the financial instrument in Level 2. In cases where quoted market prices are not available, fair values are based on estimates using discounted cash flows, present value or other valuation techniques. Those techniques are significantly affected by the assumptions used, including the discount rates and estimates of future cash flows and we classify the financial instrument in Level 3. Accordingly, the fair value estimates may not be realized in an immediate settlement of the instrument. We used the following methods and assumptions in estimating fair values of financial instruments: • Investments available for sale — Investments available for sale are valued using quoted market prices in active markets, when available, and those investments are classified as Level 1 of the fair value hierarchy. Level 1 investments available for sale include investments such as U.S. Treasury securities and money market funds. Investments available for sale are classified as Level 2 of the fair value hierarchy if quoted market prices are not available and fair values are estimated using quoted prices of similar securities or recently executed transactions for the securities. U.S. agency securities, U.S. agency mortgage-backed securities, municipal debt securities, non-U.S. government securities, corporate debt securities, residential and commercial mortgage securities and asset-backed securities are classified as Level 2 investments. We use independent pricing sources to determine the fair value of securities available for sale in Level 1 and Level 2 of the fair value hierarchy. We use one primary pricing service to provide individual security pricing based on observable market data and receive one quote per security. To ensure securities are appropriately classified in the fair value hierarchy, we review the pricing techniques and methodologies of the independent pricing service and believe that their policies adequately consider market activity, either based on specific transactions for the issue valued or based on modeling of securities with similar credit quality, duration, yield and structure that were recently traded. U.S. agency securities, U.S. agency mortgage-backed securities, municipal debt securities, non-U.S. government securities and corporate debt securities are valued by our primary vendor using recently executed transactions and proprietary models based on observable inputs, such as interest rate spreads, yield curves and credit risk. Residential and commercial mortgage securities and asset-backed securities are valued by our primary vendor using proprietary models based on observable inputs, such as interest rate spreads, prepayment speeds and credit risk. As part of our evaluation of investment prices provided by our primary pricing service, we obtained and reviewed their pricing methodologies which include a description of how each security type is evaluated and priced. We review the reasonableness of prices received from our primary pricing service by comparison to prices obtained from additional pricing sources. We have not made any adjustments to the prices obtained from our primary pricing service. Assets and Liabilities Measured at Fair Value All assets measured at fair value are categorized in the table below based upon the lowest level of significant input to the valuations. All fair value measurements at the reporting date were on a recurring basis. March 31, 2021 (In thousands) Quoted Prices Significant Significant Total Recurring fair value measurements Financial Assets: U.S. Treasury securities $ 262,309 $ — $ — $ 262,309 U.S. agency securities — 16,138 — 16,138 U.S. agency mortgage-backed securities — 1,022,991 — 1,022,991 Municipal debt securities — 572,263 — 572,263 Non-U.S. government securities — 79,280 — 79,280 Corporate debt securities — 1,414,938 — 1,414,938 Residential and commercial mortgage securities — 446,208 — 446,208 Asset-backed securities — 473,804 — 473,804 Money market funds 413,545 — — 413,545 Total assets at fair value (1) $ 675,854 $ 4,025,622 $ — $ 4,701,476 December 31, 2020 (In thousands) Quoted Prices Significant Significant Total Recurring fair value measurements Financial Assets: U.S. Treasury securities $ 268,444 $ — $ — $ 268,444 U.S. agency securities — 18,085 — 18,085 U.S. agency mortgage-backed securities — 995,905 — 995,905 Municipal debt securities — 551,517 — 551,517 Non-U.S. government securities — 61,607 — 61,607 Corporate debt securities — 1,126,512 — 1,126,512 Residential and commercial mortgage securities — 409,282 — 409,282 Asset-backed securities — 454,717 — 454,717 Money market funds 679,304 — — 679,304 Total assets at fair value (1) $ 947,748 $ 3,617,625 $ — $ 4,565,373 (1) Does not include the fair value of embedded derivatives, which we have accounted for separately as freestanding derivatives and included in other assets or other accrued liabilities in our condensed consolidated balance sheet. See Note 4 for more information. |
Statutory Accounting
Statutory Accounting | 3 Months Ended |
Mar. 31, 2021 | |
Insurance [Abstract] | |
Statutory Accounting | Statutory Accounting Our U.S. insurance subsidiaries prepare statutory-basis financial statements in accordance with the accounting practices prescribed or permitted by their respective state’s department of insurance, which is a comprehensive basis of accounting other than GAAP. We did not use any prescribed or permitted statutory accounting practices (individually or in the aggregate) that resulted in reported statutory surplus or capital that was significantly different from the statutory surplus or capital that would have been reported had National Association of Insurance Commissioners’ statutory accounting practices been followed. The following table presents Essent Guaranty’s and Essent PA’s statutory net income, statutory surplus and contingency reserve liability as of and for the three months ended March 31: (In thousands) 2021 2020 Essent Guaranty Statutory net income $ 112,401 $ 122,644 Statutory surplus 1,091,217 1,074,153 Contingency reserve liability 1,575,323 1,270,864 Essent PA Statutory net income $ 1,129 $ 1,627 Statutory surplus 54,964 53,648 Contingency reserve liability 56,535 53,854 Net income determined in accordance with statutory accounting practices differs from GAAP. In 2021 and 2020, the more significant differences between net income determined under statutory accounting practices and GAAP for Essent Guaranty and Essent PA relate to policy acquisition costs and income taxes. Under statutory accounting practices, policy acquisition costs are expensed as incurred while such costs are capitalized and amortized to expense over the life of the policy under GAAP. We are eligible for a tax deduction, subject to certain limitations for amounts required by state law or regulation to be set aside in statutory contingency reserves when we purchase non-interest-bearing United States Mortgage Guaranty Tax and Loss Bonds (“T&L Bonds”) issued by the Treasury Department. Under statutory accounting practices, this deduction reduces the tax provision recorded by Essent Guaranty and Essent PA and, as a result, increases statutory net income and surplus as compared to net income and equity determined in accordance with GAAP. At March 31, 2021 and 2020, the statutory capital of our U.S. insurance subsidiaries, which is defined as the total of statutory surplus and contingency reserves, was in excess of the statutory capital necessary to satisfy their regulatory requirements. Effective December 31, 2015, Fannie Mae and Freddie Mac, at the direction of the Federal Housing Finance Agency, implemented new coordinated Private Mortgage Insurer Eligibility Requirements, which we refer to as the "PMIERs." The PMIERs represent the standards by which private mortgage insurers are eligible to provide mortgage insurance on loans owned or guaranteed by Fannie Mae and Freddie Mac. The PMIERs include financial strength requirements incorporating a risk-based framework that require approved insurers to have a sufficient level of liquid assets from which to pay claims. The PMIERs also include enhanced operational performance expectations and define remedial actions that apply should an approved insurer fail to comply with these requirements. In 2018, the GSEs released revised PMIERs framework ("PMIERs 2.0") which became effective on March 31, 2019. As of March 31, 2021, Essent Guaranty, our GSE-approved mortgage insurance company, was in compliance with PMIERs 2.0. Statement of Statutory Accounting Principles No. 58, Mortgage Guaranty Insurance, requires mortgage insurers to establish a special contingency reserve for statutory accounting purposes included in total liabilities equal to 50% of earned premium for that year. During the three months ended March 31, 2021, Essent Guaranty increased its contingency reserve by $75.5 million and Essent PA increased its contingency reserve by $0.5 million. This reserve is required to be maintained for a period of 120 months to protect against the effects of adverse economic cycles. After 120 months, the reserve is released to unassigned funds. In the event an insurer’s loss ratio in any calendar year exceeds 35%, however, the insurer may, after regulatory approval, release from its contingency reserves an amount equal to the excess portion of such losses. During the three months ended March 31, 2021, Essent Guaranty and Essent PA released contingency reserves of $0.6 million and less than $0.1 million, respectively, to unassigned funds upon completion of the 120 month holding period. Essent Guaranty and Essent PA did not release any amounts from their contingency reserves in the three months ended March 31, 2020. Under The Insurance Act 1978, as amended, and related regulations of Bermuda (the "Insurance Act"), Essent Re is required to annually prepare statutory financial statements and a statutory financial return in accordance with the financial reporting provisions of the Insurance Act, which is a basis other than GAAP. The Insurance Act also requires that Essent Re maintain minimum share capital of $1 million and must ensure that the value of its general business assets exceeds the amount of its general business liabilities by an amount greater than the prescribed minimum solvency margins and enhanced capital requirement pertaining to its general business. At December 31, 2020, all such requirements were met. |
Recently Issued Accounting St_2
Recently Issued Accounting Standards (Policies) | 3 Months Ended |
Mar. 31, 2021 | |
Accounting Policies [Abstract] | |
Accounting Standards Not Yet Adopted | Accounting Standards Not Yet Adopted In March 2020, the Financial Accounting Standards Board ("FASB") issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting . The amendments in this update provide temporary optional guidance to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform. It provides optional expedients and exceptions for applying generally accepted accounting principles to contract, hedging relationships and other transactions affected by reference rate reform if certain criteria are met. This standard may be elected and applied prospectively over time from March 12, 2020 through December 31, 2022 as reference rate reform activities occur. The adoption of, and future elections under, this ASU are not expected to have a material impact on our consolidated financial statements as the ASU will ease, if warranted, the requirements for accounting for the future effects of the rate reform. We continue to monitor the impact the discontinuance of LIBOR or another reference rate will have on our contracts and other transactions. |
Investments (Tables)
Investments (Tables) | 3 Months Ended |
Mar. 31, 2021 | |
Investments, Debt and Equity Securities [Abstract] | |
Schedule of investments available for sale | Investments available for sale consist of the following: March 31, 2021 (In thousands) Amortized Unrealized Unrealized Fair U.S. Treasury securities $ 257,401 $ 5,854 $ (946) $ 262,309 U.S. agency securities 16,028 110 — 16,138 U.S. agency mortgage-backed securities 1,005,599 24,083 (6,691) 1,022,991 Municipal debt securities (1) 543,742 30,021 (1,500) 572,263 Non-U.S. government securities 77,440 3,818 (1,978) 79,280 Corporate debt securities (2) 1,391,881 38,183 (15,126) 1,414,938 Residential and commercial mortgage securities 439,583 12,379 (5,754) 446,208 Asset-backed securities 471,677 3,000 (873) 473,804 Money market funds 413,547 — (2) 413,545 Total investments available for sale $ 4,616,898 $ 117,448 $ (32,870) $ 4,701,476 December 31, 2020 (In thousands) Amortized Unrealized Unrealized Fair U.S. Treasury securities $ 259,378 $ 9,088 $ (22) $ 268,444 U.S. agency securities 17,930 155 — 18,085 U.S. agency mortgage-backed securities 963,670 33,205 (970) 995,905 Municipal debt securities (1) 513,870 37,662 (15) 551,517 Non-U.S. government securities 56,045 5,562 — 61,607 Corporate debt securities (2) 1,070,027 56,864 (379) 1,126,512 Residential and commercial mortgage securities 391,921 18,641 (1,280) 409,282 Asset-backed securities 452,527 3,246 (1,056) 454,717 Money market funds 679,322 — (18) 679,304 Total investments available for sale $ 4,404,690 $ 164,423 $ (3,740) $ 4,565,373 March 31, December 31, (1) The following table summarizes municipal debt securities as of : 2021 2020 Special revenue bonds 76.9 % 76.8 % General obligation bonds 20.3 20.3 Certificate of participation bonds 2.1 2.3 Tax allocation bonds 0.6 0.6 Special tax bonds 0.1 — Total 100.0 % 100.0 % March 31, December 31, (2) The following table summarizes corporate debt securities as of : 2021 2020 Financial 32.8 % 34.9 % Consumer, non-cyclical 19.2 19.1 Communications 11.6 9.3 Consumer, cyclical 7.6 8.0 Industrial 7.3 5.3 Energy 6.6 8.2 Utilities 5.9 5.9 Technology 5.4 6.1 Basic materials 3.5 3.1 Government 0.1 0.1 Total 100.0 % 100.0 % |
Schedule of amortized cost and fair value of investments available for sale by contractual maturity | The amortized cost and fair value of investments available for sale at March 31, 2021, by contractual maturity, are shown below. Expected maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. Because most U.S. agency mortgage-backed securities, residential and commercial mortgage securities and asset-backed securities provide for periodic payments throughout their lives, they are listed below in separate categories. (In thousands) Amortized Fair U.S. Treasury securities: Due in 1 year $ 51,984 $ 52,264 Due after 1 but within 5 years 155,396 158,188 Due after 5 but within 10 years 49,036 50,890 Due after 10 years 985 967 Subtotal 257,401 262,309 U.S. agency securities: Due in 1 year 12,530 12,638 Due after 1 but within 5 years 3,498 3,500 Subtotal 16,028 16,138 Municipal debt securities: Due in 1 year 7,495 7,519 Due after 1 but within 5 years 98,704 103,013 Due after 5 but within 10 years 229,338 243,858 Due after 10 years 208,205 217,873 Subtotal 543,742 572,263 Non-U.S. government securities: Due in 1 year 4,360 4,473 Due after 1 but within 5 years 18,348 19,499 Due after 5 but within 10 years 26,603 29,045 Due after 10 years 28,129 26,263 Subtotal 77,440 79,280 Corporate debt securities: Due in 1 year 147,203 148,503 Due after 1 but within 5 years 648,697 667,465 Due after 5 but within 10 years 378,395 386,311 Due after 10 years 217,586 212,659 Subtotal 1,391,881 1,414,938 U.S. agency mortgage-backed securities 1,005,599 1,022,991 Residential and commercial mortgage securities 439,583 446,208 Asset-backed securities 471,677 473,804 Money market funds 413,547 413,545 Total investments available for sale $ 4,616,898 $ 4,701,476 |
Schedule of realized gross gains and losses on sale of investments available for sale | Gross gains and losses realized on the sale of investments available for sale were as follows: Three Months Ended March 31, (In thousands) 2021 2020 Realized gross gains $ 750 $ 3,262 Realized gross losses 109 127 |
Schedule of fair value of investments in an unrealized loss position and related unrealized losses | The fair value of investments available for sale in an unrealized loss position and the related unrealized losses for which no allowance for credit loss has been recorded were as follows: Less than 12 months 12 months or more Total March 31, 2021 (In thousands) Fair Gross Fair Gross Fair Gross U.S. Treasury securities $ 88,240 $ (946) $ — $ — $ 88,240 $ (946) U.S. agency mortgage-backed securities 411,509 (6,667) 1,044 (24) 412,553 (6,691) Municipal debt securities 94,305 (1,500) — — 94,305 (1,500) Non-U.S. government securities 28,820 (1,978) — — 28,820 (1,978) Corporate debt securities 560,659 (15,112) 235 (14) 560,894 (15,126) Residential and commercial mortgage securities 191,043 (5,013) 17,628 (741) 208,671 (5,754) Asset-backed securities 131,675 (630) 39,360 (243) 171,035 (873) Money market funds 22,502 (2) — — 22,502 (2) Total $ 1,528,753 $ (31,848) $ 58,267 $ (1,022) $ 1,587,020 $ (32,870) Less than 12 months 12 months or more Total December 31, 2020 (In thousands) Fair Gross Fair Gross Fair Gross U.S. Treasury securities $ 28,776 $ (22) $ — $ — $ 28,776 $ (22) U.S. agency mortgage-backed securities 152,671 (924) 3,007 (46) 155,678 (970) Municipal debt securities 3,838 (15) — — 3,838 (15) Corporate debt securities 141,803 (379) — — 141,803 (379) Residential and commercial mortgage securities 63,203 (777) 9,516 (503) 72,719 (1,280) Asset-backed securities 124,165 (483) 65,897 (573) 190,062 (1,056) Money market funds 99,995 (18) — — 99,995 (18) Total $ 614,451 $ (2,618) $ 78,420 $ (1,122) $ 692,871 $ (3,740) |
Schedule of net investment income | Net investment income consists of: Three Months Ended March 31, (In thousands) 2021 2020 Fixed maturities $ 23,024 $ 20,614 Short-term investments 81 1,122 Gross investment income 23,105 21,736 Investment expenses (1,317) (1,103) Net investment income $ 21,788 $ 20,633 |
Reinsurance (Tables)
Reinsurance (Tables) | 3 Months Ended |
Mar. 31, 2021 | |
Reinsurance Disclosures [Abstract] | |
Effect of reinsurance | The effect of reinsurance on net premiums written and earned is as follows: Three Months Ended (In thousands) 2021 2020 Net premiums written: Direct $ 235,257 $ 205,980 Ceded (1) (30,896) (14,237) Net premiums written $ 204,361 $ 191,743 Net premiums earned: Direct $ 249,963 $ 220,733 Ceded (1) (30,896) (14,237) Net premiums earned $ 219,067 $ 206,496 (1) Net of profit commission. |
Schedule of coverages and retentions | The following table summarizes Essent Guaranty's excess of loss reinsurance agreements as of March 31, 2021: Vintage Year Reinsurer Effective Date Optional Termination Date 2015 & 2016 Radnor Re 2019-2 Ltd. June 20, 2019 June 25, 2024 2017 Radnor Re 2018-1 Ltd. March 22, 2018 March 25, 2023 (1) 2017 Panel of Reinsurers November 1, 2018 October 1, 2023 (2) 2018 Radnor Re 2019-1 Ltd. February 28, 2019 February 25, 2026 2018 Panel of Reinsurers February 28, 2019 February 25, 2026 2019 Radnor Re 2020-1 Ltd. January 30, 2020 January 25, 2027 2019 Panel of Reinsurers January 30, 2020 January 25, 2027 2019 & 2020 Radnor Re 2020-2 Ltd. October 8, 2020 October 25, 2027 (1) If the reinsurance agreement is not terminated at the optional termination date, the risk margin component of the reinsurance premium increases by 50%. (2) If the reinsurance agreement is not terminated at the optional termination date, the reinsurance premium increases by 50%. The following table summarizes Essent Guaranty's excess of loss reinsurance coverages and retentions as of March 31, 2021: (In thousands) Remaining Vintage Year Remaining Remaining ILN Other Reinsurance Total Remaining 2015 & 2016 $ 13,987,747 $ 3,777,142 $ 216,480 $ — $ 216,480 $ 207,588 2017 13,285,965 3,404,783 242,123 165,167 (5) 407,290 218,262 2018 15,328,438 3,897,423 325,537 76,144 (6) 401,681 250,350 2019 (3) 18,493,963 4,724,213 495,889 55,102 (7) 550,991 215,481 2019 & 2020 (4) 43,365,923 10,872,860 399,159 — 399,159 465,690 Total $ 104,462,036 $ 26,676,421 $ 1,679,188 $ 296,413 $ 1,975,601 $ 1,357,371 (3) Reinsurance coverage on new insurance written from January 1, 2019 through August 31, 2019. (4) Reinsurance coverage on new insurance written from September 1, 2019 through July 31, 2020. (5) Coverage provided immediately above the coverage provided by Radnor Re 2018-1 Ltd. (6) Coverage provided pari-passu to the coverage provided by Radnor Re 2019-1 Ltd. (7) Coverage provided pari-passu to the coverage provided by Radnor Re 2020-1 Ltd. |
Schedule of VIE assets and maximum exposure | The following table presents total assets of each Radnor Re special purpose insurer as well as our maximum exposure to loss associated with each Radnor Re entity, representing the fair value of the embedded derivative, using observable inputs in active markets (Level 2), included in other assets (other accrued liabilities) on our condensed consolidated balance sheet and the estimated net present value of investment earnings on the assets in the reinsurance trust, each as of March 31, 2021: Maximum Exposure to Loss (In thousands) Total VIE Assets On - Balance Sheet Off - Balance Sheet Total Radnor Re 2018-1 Ltd. $ 242,123 $ 367 $ 40 $ 407 Radnor Re 2019-1 Ltd. 325,537 (2,183) 67 (2,116) Radnor Re 2019-2 Ltd. 216,480 (1,603) 31 (1,572) Radnor Re 2020-1 Ltd. 495,889 (1,202) 126 (1,076) Radnor Re 2020-2 Ltd. 399,159 (330) 93 (237) Total $ 1,679,188 $ (4,951) $ 357 $ (4,594) |
Reserve for Losses and Loss A_2
Reserve for Losses and Loss Adjustment Expenses (Tables) | 3 Months Ended |
Mar. 31, 2021 | |
Liability for Future Policy Benefits and Unpaid Claims and Claims Adjustment Expense [Abstract] | |
Schedule of reconciliation of beginning and ending reserve balances for losses and loss adjustment expenses (LAE) | The following table provides a reconciliation of the beginning and ending reserve balances for losses and loss adjustment expenses (“LAE”) for the three months ended March 31: (In thousands) 2021 2020 Reserve for losses and LAE at beginning of period $ 374,941 $ 69,362 Less: Reinsurance recoverables 19,061 71 Net reserve for losses and LAE at beginning of period 355,880 69,291 Add provision for losses and LAE, net of reinsurance, occurring in: Current period 47,989 15,419 Prior years (15,667) (7,356) Net incurred losses and LAE during the current period 32,322 8,063 Deduct payments for losses and LAE, net of reinsurance, occurring in: Current period 114 1 Prior years 1,872 4,110 Net loss and LAE payments during the current period 1,986 4,111 Net reserve for losses and LAE at end of period 386,216 73,243 Plus: Reinsurance recoverables 24,907 98 Reserve for losses and LAE at end of period $ 411,123 $ 73,341 |
Capital Stock (Tables)
Capital Stock (Tables) | 3 Months Ended |
Mar. 31, 2021 | |
Banking Regulation, Total Capital [Abstract] | |
Schedule of dividends declared and paid per common share | The following table presents the amounts declared and paid per common share each quarter: Quarter Ended 2020 March 31 $ 0.16 June 30 0.16 September 30 0.16 December 31 0.16 Total dividends per common share declared and paid $ 0.64 Quarter Ended 2021 March 31 $ 0.16 Total dividends per common share declared and paid $ 0.16 |
Stock-Based Compensation (Table
Stock-Based Compensation (Tables) | 3 Months Ended |
Mar. 31, 2021 | |
Share-based Payment Arrangement [Abstract] | |
Summary of nonvested Common Share and nonvested Common Share unit activity | The following table summarizes nonvested common share, nonvested common share unit and DEU activity for the three months ended March 31, 2021: Time and Performance- Time-Based Share Units DEUs (Shares in thousands) Number of Weighted Number of Weighted Number of Weighted Dividend Equivalent Units Weighted Outstanding at beginning of year 363 $ 47.09 153 $ 46.34 492 $ 46.59 21 $ 37.66 Granted 281 15.64 93 43.67 87 43.65 4 43.50 Vested (113) 45.02 (77) 45.36 (164) 48.01 (8) 38.14 Forfeited — N/A — N/A (6) 50.43 — 36.11 Outstanding at March 31, 2021 531 $ 30.89 169 $ 45.31 409 $ 45.34 17 $ 38.85 |
Schedule of portion of nonvested Common Shares earned based upon achievement of compounded annual book value per share growth | The portion of these nonvested performance-based share awards that will be earned is as follows: Relative Total Shareholder Return ≤25th percentile 50th percentile ≥75th percentile Three-Year Book 14% "Target" 100 % 150 % 200 % 12% 75 % 125 % 175 % 10% 50 % 100 % 150 % 8% 25 % 75 % 125 % 6% 0 % 50 % 100 % |
Schedule of compensation expense, net of forfeitures, and related tax effects recognized in connection with nonvested shares | Compensation expense, net of forfeitures, and related tax effects recognized in connection with nonvested shares was as follows: Three Months Ended March 31, (In thousands) 2021 2020 Compensation expense $ 5,179 $ 4,780 Income tax benefit 986 918 |
Earnings per Share (EPS) (Table
Earnings per Share (EPS) (Tables) | 3 Months Ended |
Mar. 31, 2021 | |
Earnings Per Share [Abstract] | |
Schedule of reconciliation of net income and weighted average common shares outstanding used in computations of basic and diluted earnings per common share | The following table reconciles the net income and the weighted average common shares outstanding used in the computations of basic and diluted earnings per common share: Three Months Ended (In thousands, except per share amounts) 2021 2020 Net income $ 135,648 $ 149,523 Basic weighted average shares outstanding 112,016 97,949 Dilutive effect of nonvested shares 362 377 Diluted weighted average shares outstanding 112,378 98,326 Basic earnings per share $ 1.21 $ 1.53 Diluted earnings per share $ 1.21 $ 1.52 |
Accumulated Other Comprehensi_2
Accumulated Other Comprehensive Income (Loss) (Tables) | 3 Months Ended |
Mar. 31, 2021 | |
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] | |
Rollforward of accumulated other comprehensive income (loss) | The following table presents the rollforward of accumulated other comprehensive income (loss) for the three months ended March 31, 2021 and 2020: Three Months Ended March 31, 2021 2020 (In thousands) Before Tax Tax Effect Net of Tax Before Tax Tax Effect Net of Tax Balance at beginning of period $ 168,324 $ (30,050) $ 138,274 $ 69,401 $ (13,214) $ 56,187 Other comprehensive income (loss): Unrealized holding gains (losses) on investments: Unrealized holding losses arising during the period (68,763) 10,201 (58,562) (13,918) 6,403 (7,515) Less: Reclassification adjustment for gains included in net income (1) (641) — (641) (3,135) 576 (2,559) Net unrealized losses on investments (69,404) 10,201 (59,203) (17,053) 6,979 (10,074) Other comprehensive loss (69,404) 10,201 (59,203) (17,053) 6,979 (10,074) Balance at end of period $ 98,920 $ (19,849) $ 79,071 $ 52,348 $ (6,235) $ 46,113 (1) Included in net realized investment gains (losses) on our condensed consolidated statements of comprehensive income. |
Fair Value of Financial Instr_2
Fair Value of Financial Instruments (Tables) | 3 Months Ended |
Mar. 31, 2021 | |
Fair Value Disclosures [Abstract] | |
Schedule of assets and liabilities measured at fair vale on a recurring basis | All assets measured at fair value are categorized in the table below based upon the lowest level of significant input to the valuations. All fair value measurements at the reporting date were on a recurring basis. March 31, 2021 (In thousands) Quoted Prices Significant Significant Total Recurring fair value measurements Financial Assets: U.S. Treasury securities $ 262,309 $ — $ — $ 262,309 U.S. agency securities — 16,138 — 16,138 U.S. agency mortgage-backed securities — 1,022,991 — 1,022,991 Municipal debt securities — 572,263 — 572,263 Non-U.S. government securities — 79,280 — 79,280 Corporate debt securities — 1,414,938 — 1,414,938 Residential and commercial mortgage securities — 446,208 — 446,208 Asset-backed securities — 473,804 — 473,804 Money market funds 413,545 — — 413,545 Total assets at fair value (1) $ 675,854 $ 4,025,622 $ — $ 4,701,476 December 31, 2020 (In thousands) Quoted Prices Significant Significant Total Recurring fair value measurements Financial Assets: U.S. Treasury securities $ 268,444 $ — $ — $ 268,444 U.S. agency securities — 18,085 — 18,085 U.S. agency mortgage-backed securities — 995,905 — 995,905 Municipal debt securities — 551,517 — 551,517 Non-U.S. government securities — 61,607 — 61,607 Corporate debt securities — 1,126,512 — 1,126,512 Residential and commercial mortgage securities — 409,282 — 409,282 Asset-backed securities — 454,717 — 454,717 Money market funds 679,304 — — 679,304 Total assets at fair value (1) $ 947,748 $ 3,617,625 $ — $ 4,565,373 (1) Does not include the fair value of embedded derivatives, which we have accounted for separately as freestanding derivatives and included in other assets or other accrued liabilities in our condensed consolidated balance sheet. See Note 4 for more information. |
Statutory Accounting (Tables)
Statutory Accounting (Tables) | 3 Months Ended |
Mar. 31, 2021 | |
Insurance [Abstract] | |
Schedule of statutory net income, statutory surplus and contingency reserve liability | The following table presents Essent Guaranty’s and Essent PA’s statutory net income, statutory surplus and contingency reserve liability as of and for the three months ended March 31: (In thousands) 2021 2020 Essent Guaranty Statutory net income $ 112,401 $ 122,644 Statutory surplus 1,091,217 1,074,153 Contingency reserve liability 1,575,323 1,270,864 Essent PA Statutory net income $ 1,129 $ 1,627 Statutory surplus 54,964 53,648 Contingency reserve liability 56,535 53,854 |
Nature of Operations and Basi_2
Nature of Operations and Basis of Presentation (Details) - state | Jan. 01, 2021 | Mar. 31, 2019 | Dec. 31, 2020 | Mar. 31, 2021 |
Essent Guaranty | ||||
Insurance Premium Revenue Recognition | ||||
Number of states in which the entity is licensed to write mortgage insurance | 50 | |||
Essent Re | Affiliated Entity | Quota share reinsurance | ||||
Insurance Premium Revenue Recognition | ||||
Reinsurance percentage | 35.00% | 25.00% | 25.00% | |
Essent PA | Affiliated Entity | Reinsurance for mortgage insurance coverage in excess of 25% | ||||
Insurance Premium Revenue Recognition | ||||
Reinsurance for mortgage insurance coverage threshold (in excess of) | 25.00% | |||
Maximum | ||||
Insurance Premium Revenue Recognition | ||||
Residential mortgage down payment percentage for which mortgage insurance is generally required (less than) | 20.00% |
Investments - Schedule of Inves
Investments - Schedule of Investments Available for Sale (Details) - USD ($) $ in Thousands | Mar. 31, 2021 | Dec. 31, 2020 |
Investments available for sale | ||
Amortized Cost | $ 4,616,898 | $ 4,404,690 |
Unrealized Gains | 117,448 | 164,423 |
Unrealized Losses | (32,870) | (3,740) |
Fair Value | 4,701,476 | 4,565,373 |
U.S. Treasury securities | ||
Investments available for sale | ||
Amortized Cost | 257,401 | 259,378 |
Unrealized Gains | 5,854 | 9,088 |
Unrealized Losses | (946) | (22) |
Fair Value | 262,309 | 268,444 |
U.S. agency securities | ||
Investments available for sale | ||
Amortized Cost | 16,028 | 17,930 |
Unrealized Gains | 110 | 155 |
Unrealized Losses | 0 | 0 |
Fair Value | 16,138 | 18,085 |
U.S. agency mortgage-backed securities | ||
Investments available for sale | ||
Amortized Cost | 1,005,599 | 963,670 |
Unrealized Gains | 24,083 | 33,205 |
Unrealized Losses | (6,691) | (970) |
Fair Value | 1,022,991 | 995,905 |
Municipal debt securities | ||
Investments available for sale | ||
Amortized Cost | 543,742 | 513,870 |
Unrealized Gains | 30,021 | 37,662 |
Unrealized Losses | (1,500) | (15) |
Fair Value | 572,263 | 551,517 |
Non-U.S. government securities | ||
Investments available for sale | ||
Amortized Cost | 77,440 | 56,045 |
Unrealized Gains | 3,818 | 5,562 |
Unrealized Losses | (1,978) | 0 |
Fair Value | 79,280 | 61,607 |
Corporate debt securities | ||
Investments available for sale | ||
Amortized Cost | 1,391,881 | 1,070,027 |
Unrealized Gains | 38,183 | 56,864 |
Unrealized Losses | (15,126) | (379) |
Fair Value | 1,414,938 | 1,126,512 |
Residential and commercial mortgage securities | ||
Investments available for sale | ||
Amortized Cost | 439,583 | 391,921 |
Unrealized Gains | 12,379 | 18,641 |
Unrealized Losses | (5,754) | (1,280) |
Fair Value | 446,208 | 409,282 |
Asset-backed securities | ||
Investments available for sale | ||
Amortized Cost | 471,677 | 452,527 |
Unrealized Gains | 3,000 | 3,246 |
Unrealized Losses | (873) | (1,056) |
Fair Value | 473,804 | 454,717 |
Money market funds | ||
Investments available for sale | ||
Amortized Cost | 413,547 | 679,322 |
Unrealized Gains | 0 | 0 |
Unrealized Losses | (2) | (18) |
Fair Value | $ 413,545 | $ 679,304 |
Investments - Summary of Munici
Investments - Summary of Municipal Debt Securities and Corporate Debt Securities (Details) | Mar. 31, 2021 | Dec. 31, 2020 |
Municipal debt securities | ||
Investments available for sale | ||
Percentage of debt securities | 100.00% | 100.00% |
Municipal debt securities | Special revenue bonds | ||
Investments available for sale | ||
Percentage of debt securities | 76.90% | 76.80% |
Municipal debt securities | General obligation bonds | ||
Investments available for sale | ||
Percentage of debt securities | 20.30% | 20.30% |
Municipal debt securities | Certificate of participation bonds | ||
Investments available for sale | ||
Percentage of debt securities | 2.10% | 2.30% |
Municipal debt securities | Tax allocation bonds | ||
Investments available for sale | ||
Percentage of debt securities | 0.60% | 0.60% |
Municipal debt securities | Special tax bonds | ||
Investments available for sale | ||
Percentage of debt securities | 0.10% | 0.00% |
Corporate debt securities | ||
Investments available for sale | ||
Percentage of debt securities | 100.00% | 100.00% |
Corporate debt securities | Financial | ||
Investments available for sale | ||
Percentage of debt securities | 32.80% | 34.90% |
Corporate debt securities | Consumer, non-cyclical | ||
Investments available for sale | ||
Percentage of debt securities | 19.20% | 19.10% |
Corporate debt securities | Communications | ||
Investments available for sale | ||
Percentage of debt securities | 11.60% | 9.30% |
Corporate debt securities | Consumer, cyclical | ||
Investments available for sale | ||
Percentage of debt securities | 7.60% | 8.00% |
Corporate debt securities | Industrial | ||
Investments available for sale | ||
Percentage of debt securities | 7.30% | 5.30% |
Corporate debt securities | Energy | ||
Investments available for sale | ||
Percentage of debt securities | 6.60% | 8.20% |
Corporate debt securities | Utilities | ||
Investments available for sale | ||
Percentage of debt securities | 5.90% | 5.90% |
Corporate debt securities | Technology | ||
Investments available for sale | ||
Percentage of debt securities | 5.40% | 6.10% |
Corporate debt securities | Basic materials | ||
Investments available for sale | ||
Percentage of debt securities | 3.50% | 3.10% |
Corporate debt securities | Government | ||
Investments available for sale | ||
Percentage of debt securities | 0.10% | 0.10% |
Investments - Schedule of Amort
Investments - Schedule of Amortized Cost and Fair Value of Investments Available for Sale by Contractual Maturity (Details) - USD ($) $ in Thousands | Mar. 31, 2021 | Dec. 31, 2020 |
Amortized Cost | ||
Amortized Cost | $ 4,616,898 | $ 4,404,690 |
Fair Value | ||
Fair Value | 4,701,476 | 4,565,373 |
U.S. Treasury securities | ||
Amortized Cost | ||
Due in 1 year | 51,984 | |
Due after 1 but within 5 years | 155,396 | |
Due after 5 but within 10 years | 49,036 | |
Due after 10 years | 985 | |
Subtotal | 257,401 | |
Amortized Cost | 257,401 | 259,378 |
Fair Value | ||
Due in 1 year | 52,264 | |
Due after 1 but within 5 years | 158,188 | |
Due after 5 but within 10 years | 50,890 | |
Due after 10 years | 967 | |
Subtotal | 262,309 | |
U.S. agency securities | ||
Amortized Cost | ||
Due in 1 year | 12,530 | |
Due after 1 but within 5 years | 3,498 | |
Subtotal | 16,028 | |
Amortized Cost | 16,028 | 17,930 |
Fair Value | ||
Due in 1 year | 12,638 | |
Due after 1 but within 5 years | 3,500 | |
Subtotal | 16,138 | |
Municipal debt securities | ||
Amortized Cost | ||
Due in 1 year | 7,495 | |
Due after 1 but within 5 years | 98,704 | |
Due after 5 but within 10 years | 229,338 | |
Due after 10 years | 208,205 | |
Subtotal | 543,742 | |
Amortized Cost | 543,742 | 513,870 |
Fair Value | ||
Due in 1 year | 7,519 | |
Due after 1 but within 5 years | 103,013 | |
Due after 5 but within 10 years | 243,858 | |
Due after 10 years | 217,873 | |
Subtotal | 572,263 | |
Non-U.S. government securities: | ||
Amortized Cost | ||
Due in 1 year | 4,360 | |
Due after 1 but within 5 years | 18,348 | |
Due after 5 but within 10 years | 26,603 | |
Due after 10 years | 28,129 | |
Subtotal | 77,440 | |
Amortized Cost | 77,440 | 56,045 |
Fair Value | ||
Due in 1 year | 4,473 | |
Due after 1 but within 5 years | 19,499 | |
Due after 5 but within 10 years | 29,045 | |
Due after 10 years | 26,263 | |
Subtotal | 79,280 | |
Corporate debt securities | ||
Amortized Cost | ||
Due in 1 year | 147,203 | |
Due after 1 but within 5 years | 648,697 | |
Due after 5 but within 10 years | 378,395 | |
Due after 10 years | 217,586 | |
Subtotal | 1,391,881 | |
Amortized Cost | 1,391,881 | 1,070,027 |
Fair Value | ||
Due in 1 year | 148,503 | |
Due after 1 but within 5 years | 667,465 | |
Due after 5 but within 10 years | 386,311 | |
Due after 10 years | 212,659 | |
Subtotal | 1,414,938 | |
U.S. agency mortgage-backed securities | ||
Amortized Cost | ||
Without single maturity date | 1,005,599 | |
Amortized Cost | 1,005,599 | 963,670 |
Fair Value | ||
Without single maturity date | 1,022,991 | |
Residential and commercial mortgage securities | ||
Amortized Cost | ||
Without single maturity date | 439,583 | |
Amortized Cost | 439,583 | 391,921 |
Fair Value | ||
Without single maturity date | 446,208 | |
Asset-backed securities | ||
Amortized Cost | ||
Without single maturity date | 471,677 | |
Amortized Cost | 471,677 | 452,527 |
Fair Value | ||
Without single maturity date | 473,804 | |
Money market funds | ||
Amortized Cost | ||
Without single maturity date | 413,547 | |
Amortized Cost | 413,547 | $ 679,322 |
Fair Value | ||
Without single maturity date | $ 413,545 |
Investments - Summary of Realiz
Investments - Summary of Realized Gain and Loss and Investments in Unrealized Loss Position (Details) - USD ($) $ in Thousands | 3 Months Ended | ||
Mar. 31, 2021 | Mar. 31, 2020 | Dec. 31, 2020 | |
Investments, Debt and Equity Securities [Abstract] | |||
Realized gross gains | $ 750 | $ 3,262 | |
Realized gross losses | 109 | $ 127 | |
Fair Value | |||
Less than 12 months | 1,528,753 | $ 614,451 | |
12 months or more | 58,267 | 78,420 | |
Total | 1,587,020 | 692,871 | |
Gross Unrealized Losses | |||
Less than 12 months | (31,848) | (2,618) | |
12 months or more | (1,022) | (1,122) | |
Total | (32,870) | (3,740) | |
U.S. Treasury securities | |||
Fair Value | |||
Less than 12 months | 88,240 | 28,776 | |
12 months or more | 0 | 0 | |
Total | 88,240 | 28,776 | |
Gross Unrealized Losses | |||
Less than 12 months | (946) | (22) | |
12 months or more | 0 | 0 | |
Total | (946) | (22) | |
U.S. agency mortgage-backed securities | |||
Fair Value | |||
Less than 12 months | 411,509 | 152,671 | |
12 months or more | 1,044 | 3,007 | |
Total | 412,553 | 155,678 | |
Gross Unrealized Losses | |||
Less than 12 months | (6,667) | (924) | |
12 months or more | (24) | (46) | |
Total | (6,691) | (970) | |
Municipal debt securities | |||
Fair Value | |||
Less than 12 months | 94,305 | 3,838 | |
12 months or more | 0 | 0 | |
Total | 94,305 | 3,838 | |
Gross Unrealized Losses | |||
Less than 12 months | (1,500) | (15) | |
12 months or more | 0 | 0 | |
Total | (1,500) | (15) | |
Non-U.S. government securities: | |||
Fair Value | |||
Less than 12 months | 28,820 | ||
12 months or more | 0 | ||
Total | 28,820 | ||
Gross Unrealized Losses | |||
Less than 12 months | (1,978) | ||
12 months or more | 0 | ||
Total | (1,978) | ||
Corporate debt securities | |||
Fair Value | |||
Less than 12 months | 560,659 | 141,803 | |
12 months or more | 235 | 0 | |
Total | 560,894 | 141,803 | |
Gross Unrealized Losses | |||
Less than 12 months | (15,112) | (379) | |
12 months or more | (14) | 0 | |
Total | (15,126) | (379) | |
Residential and commercial mortgage securities | |||
Fair Value | |||
Less than 12 months | 191,043 | 63,203 | |
12 months or more | 17,628 | 9,516 | |
Total | 208,671 | 72,719 | |
Gross Unrealized Losses | |||
Less than 12 months | (5,013) | (777) | |
12 months or more | (741) | (503) | |
Total | (5,754) | (1,280) | |
Asset-backed securities | |||
Fair Value | |||
Less than 12 months | 131,675 | 124,165 | |
12 months or more | 39,360 | 65,897 | |
Total | 171,035 | 190,062 | |
Gross Unrealized Losses | |||
Less than 12 months | (630) | (483) | |
12 months or more | (243) | (573) | |
Total | (873) | (1,056) | |
Money market funds | |||
Fair Value | |||
Less than 12 months | 22,502 | 99,995 | |
12 months or more | 0 | 0 | |
Total | 22,502 | 99,995 | |
Gross Unrealized Losses | |||
Less than 12 months | (2) | (18) | |
12 months or more | 0 | 0 | |
Total | $ (2) | $ (18) |
Investments - Narrative (Detail
Investments - Narrative (Details) | 3 Months Ended | ||
Mar. 31, 2021USD ($)security | Mar. 31, 2020USD ($) | Dec. 31, 2020USD ($)security | |
Investments available for sale | |||
Number of investment securities in an unrealized loss position | security | 802 | 363 | |
Other-than-temporary impairments | $ 0 | $ 0 | |
Other invested assets | 100,393,000 | $ 88,904,000 | |
Fair value of investments deposited with insurance regulatory authorities | 9,400,000 | 9,700,000 | |
Essent Re | |||
Investments available for sale | |||
Fair value of the required investments on deposit in trusts | 1,200,000,000 | 1,100,000,000 | |
Essent Guaranty | |||
Investments available for sale | |||
Assets on deposit under reinsurance agreement | 8,500,000 | 8,500,000 | |
Assets on deposit for the benefit of the sponsor | $ 12,000,000 | $ 12,000,000 | |
Securities | Credit Concentration Risk | Internal Investment Grade | |||
Investments available for sale | |||
Concentration risk, percentage | 98.00% |
Investments - Net Investment In
Investments - Net Investment Income (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2020 | |
Components of net investment income | ||
Gross investment income | $ 23,105 | $ 21,736 |
Investment expenses | (1,317) | (1,103) |
Net investment income | 21,788 | 20,633 |
Fixed maturities | ||
Components of net investment income | ||
Gross investment income | 23,024 | 20,614 |
Short-term investments | ||
Components of net investment income | ||
Gross investment income | $ 81 | $ 1,122 |
Reinsurance - Effect on Net Pre
Reinsurance - Effect on Net Premiums Written and Earned (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2020 | |
Net premiums written: | ||
Direct | $ 235,257 | $ 205,980 |
Ceded | (30,896) | (14,237) |
Net premiums written | 204,361 | 191,743 |
Net premiums earned: | ||
Direct | 249,963 | 220,733 |
Ceded | (30,896) | (14,237) |
Net premiums earned | $ 219,067 | $ 206,496 |
Reinsurance - Quota Share Reins
Reinsurance - Quota Share Reinsurance (Details) - Quota Share Reinsurance - USD ($) $ in Billions | Sep. 01, 2019 | Dec. 31, 2022 | Mar. 31, 2021 |
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | |||
Ceded premiums earned related to percent of risk on eligible single premium policies | 40.00% | ||
Ceded premiums earned related to percent of risk on all other eligible policies written | 20.00% | ||
Ceding commission, percent | 20.00% | ||
Profit commission, percent, maximum | 60.00% | ||
RIF ceded | $ 5.8 | ||
Forecast | |||
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | |||
Profit commission, percent, maximum | 63.00% |
Reinsurance - Excess of Loss Re
Reinsurance - Excess of Loss Reinsurance (Details) - Mortgage Insurance | 3 Months Ended |
Mar. 31, 2021 | |
Essent Guaranty | Other Reinsurance | |
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | |
Amortization period | 10 years |
Variable Interest Entity, Not Primary Beneficiary | Radnor Re | |
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | |
Amortization period | 10 years |
Variable Interest Entity, Not Primary Beneficiary | Radnor Re | Mortgage Insurance Linked Notes | |
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | |
Reinsurance retention policy, debt issued to cover insurance, term | 10 years |
Reinsurance - Premium Details (
Reinsurance - Premium Details (Details) - 2017 | Mar. 31, 2021 |
Radnor Re 2018-1 Ltd. | |
Effects of Reinsurance [Line Items] | |
Increase of margin component of reinsurance premium | 50.00% |
Panel of Reinsurers | |
Effects of Reinsurance [Line Items] | |
Increase of margin component of reinsurance premium | 50.00% |
Reinsurance - Essent Guaranty's
Reinsurance - Essent Guaranty's Excess of Loss Reinsurance Coverages and Retentions (Details) $ in Thousands | 3 Months Ended |
Mar. 31, 2021USD ($) | |
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | |
Remaining Insurance in Force | $ 104,462,036 |
Remaining Risk in Force | 26,676,421 |
Remaining Reinsurance in Force | 1,975,601 |
Remaining First Layer Retention | 1,357,371 |
ILN | |
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | |
Remaining Reinsurance in Force | 1,679,188 |
Other Reinsurance | |
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | |
Remaining Reinsurance in Force | 296,413 |
2015 & 2016 | |
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | |
Remaining Insurance in Force | 13,987,747 |
Remaining Risk in Force | 3,777,142 |
Remaining Reinsurance in Force | 216,480 |
Remaining First Layer Retention | 207,588 |
2015 & 2016 | ILN 2015 & 2016 | |
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | |
Remaining Reinsurance in Force | 216,480 |
2015 & 2016 | Other Reinsurance | |
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | |
Remaining Reinsurance in Force | 0 |
2017 | |
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | |
Remaining Insurance in Force | 13,285,965 |
Remaining Risk in Force | 3,404,783 |
Remaining Reinsurance in Force | 407,290 |
Remaining First Layer Retention | 218,262 |
2017 | Radnor Re 2018-1 Ltd. | |
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | |
Remaining Reinsurance in Force | 242,123 |
2017 | Other Reinsurance | |
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | |
Remaining Reinsurance in Force | 165,167 |
2018 | |
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | |
Remaining Insurance in Force | 15,328,438 |
Remaining Risk in Force | 3,897,423 |
Remaining Reinsurance in Force | 401,681 |
Remaining First Layer Retention | 250,350 |
2018 | Radnor Re 2019-1 Ltd. | |
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | |
Remaining Reinsurance in Force | 325,537 |
2018 | Other Reinsurance | |
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | |
Remaining Reinsurance in Force | 76,144 |
2019 | |
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | |
Remaining Insurance in Force | 18,493,963 |
Remaining Risk in Force | 4,724,213 |
Remaining Reinsurance in Force | 550,991 |
Remaining First Layer Retention | 215,481 |
2019 | Radnor Re 2020-1 Ltd. | |
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | |
Remaining Reinsurance in Force | 495,889 |
2019 | Other Reinsurance | |
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | |
Remaining Reinsurance in Force | 55,102 |
2019 and 2020 | |
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | |
Remaining Insurance in Force | 43,365,923 |
Remaining Risk in Force | 10,872,860 |
Remaining Reinsurance in Force | 399,159 |
Remaining First Layer Retention | 465,690 |
2019 and 2020 | Radnor Re 2020-2 Ltd. | |
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | |
Remaining Reinsurance in Force | 399,159 |
2019 and 2020 | Other Reinsurance | |
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | |
Remaining Reinsurance in Force | $ 0 |
Reinsurance - Summary of Total
Reinsurance - Summary of Total Assets and Maximum Exposure Loss (Details) - USD ($) $ in Thousands | Mar. 31, 2021 | Dec. 31, 2020 |
Variable Interest Entity [Line Items] | ||
Total VIE Assets | $ 5,331,846 | $ 5,202,724 |
Variable Interest Entity, Not Primary Beneficiary | ||
Variable Interest Entity [Line Items] | ||
Total VIE Assets | 1,679,188 | |
Maximum Exposure to Loss, On - Balance Sheet | (4,951) | |
Maximum Exposure to Loss, Off - Balance Sheet | 357 | |
Maximum Exposure to Loss | (4,594) | |
Variable Interest Entity, Not Primary Beneficiary | Radnor Re 2018-1 Ltd. | ||
Variable Interest Entity [Line Items] | ||
Total VIE Assets | 242,123 | |
Maximum Exposure to Loss, On - Balance Sheet | 367 | |
Maximum Exposure to Loss, Off - Balance Sheet | 40 | |
Maximum Exposure to Loss | 407 | |
Variable Interest Entity, Not Primary Beneficiary | Radnor Re 2019-1 Ltd. | ||
Variable Interest Entity [Line Items] | ||
Total VIE Assets | 325,537 | |
Maximum Exposure to Loss, On - Balance Sheet | (2,183) | |
Maximum Exposure to Loss, Off - Balance Sheet | 67 | |
Maximum Exposure to Loss | (2,116) | |
Variable Interest Entity, Not Primary Beneficiary | Radnor Re 2019-2 Ltd. | ||
Variable Interest Entity [Line Items] | ||
Total VIE Assets | 216,480 | |
Maximum Exposure to Loss, On - Balance Sheet | (1,603) | |
Maximum Exposure to Loss, Off - Balance Sheet | 31 | |
Maximum Exposure to Loss | (1,572) | |
Variable Interest Entity, Not Primary Beneficiary | Radnor Re 2020-1 Ltd. | ||
Variable Interest Entity [Line Items] | ||
Total VIE Assets | 495,889 | |
Maximum Exposure to Loss, On - Balance Sheet | (1,202) | |
Maximum Exposure to Loss, Off - Balance Sheet | 126 | |
Maximum Exposure to Loss | (1,076) | |
Variable Interest Entity, Not Primary Beneficiary | Radnor Re 2020-2 Ltd. | ||
Variable Interest Entity [Line Items] | ||
Total VIE Assets | 399,159 | |
Maximum Exposure to Loss, On - Balance Sheet | (330) | |
Maximum Exposure to Loss, Off - Balance Sheet | 93 | |
Maximum Exposure to Loss | $ (237) |
Reserve for Losses and Loss A_3
Reserve for Losses and Loss Adjustment Expenses - Reconciliation of Reserve Balances for Losses and Loss Adjustment Expense (Details) - USD ($) $ in Thousands | 3 Months Ended | |||
Mar. 31, 2021 | Mar. 31, 2020 | Dec. 31, 2020 | Dec. 31, 2019 | |
Reconciliation of the beginning and ending reserve balances for losses and loss adjustment expenses (LAE) | ||||
Reserve for losses and LAE at beginning of period | $ 374,941 | $ 69,362 | ||
Less: Reinsurance recoverables | 24,907 | 98 | $ 19,061 | $ 71 |
Net reserve for losses and LAE at beginning of period | 355,880 | 69,291 | ||
Add provision for losses and LAE, net of reinsurance, occurring in: | ||||
Current period | 47,989 | 15,419 | ||
Prior years | (15,667) | (7,356) | ||
Net incurred losses and LAE during the current period | 32,322 | 8,063 | ||
Deduct payments for losses and LAE, net of reinsurance, occurring in: | ||||
Current period | 114 | 1 | ||
Prior years | 1,872 | 4,110 | ||
Net loss and LAE payments during the current period | 1,986 | 4,111 | ||
Net reserve for losses and LAE at end of period | 386,216 | 73,243 | ||
Plus: Reinsurance recoverables | 24,907 | 98 | $ 19,061 | $ 71 |
Reserve for losses and LAE at end of period | $ 411,123 | $ 73,341 |
Reserve for Losses and Loss A_4
Reserve for Losses and Loss Adjustment Expenses - Narrative (Details) $ in Thousands | 3 Months Ended | 6 Months Ended | |||
Mar. 31, 2021USD ($)loan | Mar. 31, 2020USD ($) | Sep. 30, 2020 | Dec. 31, 2020USD ($) | Dec. 31, 2019USD ($) | |
Liability for Future Policy Benefits and Unpaid Claims and Claims Adjustment Expense [Abstract] | |||||
Incurred claims and claim adjustment expenses | $ 1,872 | $ 4,110 | |||
Favorable prior year development | 15,667 | 7,356 | |||
Reserve for losses and LAE, for prior years | $ 338,300 | 57,800 | |||
Debt Instrument [Line Items] | |||||
Loans in default at end of period | loan | 29,080 | ||||
Reserve for losses and LAE | $ 411,123 | $ 73,341 | $ 374,941 | $ 69,362 | |
COVID-19 | |||||
Debt Instrument [Line Items] | |||||
Loans in default at end of period | loan | 26,874 | ||||
Reserve rate | 7.00% | ||||
Reserve for losses and LAE | $ 362,900 | ||||
Percent change used in calculation of expense | 1.00% | ||||
Effect of percentage point decrease on liability claim and claim expense adjustment expense | $ 35,000 | ||||
Early COVID-19 defaults | |||||
Debt Instrument [Line Items] | |||||
Reserve for losses and LAE | $ 244,800 |
Debt Obligations (Details)
Debt Obligations (Details) - USD ($) $ in Millions | Mar. 31, 2021 | Dec. 31, 2020 |
Credit Facility [Line Items] | ||
Credit facility, maximum borrowing capacity | $ 625 | |
Option to increase capacity | 775 | |
Amount outstanding, gross | $ 325 | $ 325 |
Weighted average interest during period | 2.13% | 2.19% |
Revolving Credit Facility | ||
Credit Facility [Line Items] | ||
Credit facility, maximum borrowing capacity | $ 300 | |
Annual commitment fee rate | 0.35% | |
Term Loan | ||
Credit Facility [Line Items] | ||
Credit facility, maximum borrowing capacity | $ 325 |
Commitments and Contingencies -
Commitments and Contingencies - Narrative (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2020 | |
Indemnifications related to contract underwriting services | ||
Loss Contingencies [Line Items] | ||
Amount paid for remedies (less than) | $ 0.1 | $ 0.1 |
Capital Stock - Narrative (Deta
Capital Stock - Narrative (Details) $ / shares in Units, shares in Thousands, $ in Millions | May 07, 2021USD ($)$ / shares | Mar. 31, 2021vote$ / sharesshares | Dec. 31, 2020$ / sharesshares | Sep. 30, 2020$ / shares | Jun. 30, 2020$ / shares | Mar. 31, 2020$ / shares | Dec. 31, 2020$ / sharesshares |
Dividends Payable [Line Items] | |||||||
Common shares, authorized (in shares) | shares | 233,333 | 233,333 | 233,333 | ||||
Number of votes per share | vote | 1 | ||||||
Maximum percent of individual ownership | 9.50% | ||||||
Minimum number of votes per share for other shareholders under 9.5% shareholder provision | vote | 1 | ||||||
Quarterly cash dividends declared (in dollars per share) | $ / shares | $ 0.16 | $ 0.16 | $ 0.16 | $ 0.16 | $ 0.16 | $ 0.64 | |
Subsequent event | |||||||
Dividends Payable [Line Items] | |||||||
Quarterly cash dividends declared (in dollars per share) | $ / shares | $ 0.17 | ||||||
Share repurchase approved amount | $ | $ 250 |
Capital Stock - Dividends (Deta
Capital Stock - Dividends (Details) - $ / shares | 3 Months Ended | 12 Months Ended | ||||
Mar. 31, 2021 | Dec. 31, 2020 | Sep. 30, 2020 | Jun. 30, 2020 | Mar. 31, 2020 | Dec. 31, 2020 | |
Banking Regulation, Total Capital [Abstract] | ||||||
Quarterly cash dividends paid (in dollars per share) | $ 0.16 | $ 0.16 | $ 0.16 | $ 0.16 | $ 0.16 | $ 0.64 |
Stock-Based Compensation - Summ
Stock-Based Compensation - Summary of Nonvested Common Share and Common Share Unit Activity (Details) shares in Thousands | 3 Months Ended |
Mar. 31, 2021$ / sharesshares | |
Nonvested shares | Time and Performance- Based Share Awards | |
Number of Shares | |
Outstanding at beginning of year (in shares) | 363 |
Granted (in shares) | 281 |
Vested (in shares) | (113) |
Forfeited (in shares) | 0 |
Outstanding at end of period (in shares) | 531 |
Weighted Average Grant Date Fair Value | |
Outstanding at beginning of year (in dollars per share) | $ / shares | $ 47.09 |
Granted (in dollars per share) | $ / shares | 15.64 |
Vested (in dollars per share) | $ / shares | 45.02 |
Outstanding at end of period (in dollars per share) | $ / shares | $ 30.89 |
Nonvested shares | Time-Based Share Awards | |
Number of Shares | |
Outstanding at beginning of year (in shares) | 153 |
Granted (in shares) | 93 |
Vested (in shares) | (77) |
Forfeited (in shares) | 0 |
Outstanding at end of period (in shares) | 169 |
Weighted Average Grant Date Fair Value | |
Outstanding at beginning of year (in dollars per share) | $ / shares | $ 46.34 |
Granted (in dollars per share) | $ / shares | 43.67 |
Vested (in dollars per share) | $ / shares | 45.36 |
Outstanding at end of period (in dollars per share) | $ / shares | $ 45.31 |
Share Units | |
Number of Shares | |
Outstanding at beginning of year (in shares) | 492 |
Granted (in shares) | 87 |
Vested (in shares) | (164) |
Forfeited (in shares) | (6) |
Outstanding at end of period (in shares) | 409 |
Weighted Average Grant Date Fair Value | |
Outstanding at beginning of year (in dollars per share) | $ / shares | $ 46.59 |
Granted (in dollars per share) | $ / shares | 43.65 |
Vested (in dollars per share) | $ / shares | 48.01 |
Forfeited (in dollars per share) | $ / shares | 50.43 |
Outstanding at end of period (in dollars per share) | $ / shares | $ 45.34 |
DEUs | |
Number of Shares | |
Outstanding at beginning of year (in shares) | 21 |
Granted (in shares) | 4 |
Vested (in shares) | (8) |
Forfeited (in shares) | 0 |
Outstanding at end of period (in shares) | 17 |
Weighted Average Grant Date Fair Value | |
Outstanding at beginning of year (in dollars per share) | $ / shares | $ 37.66 |
Granted (in dollars per share) | $ / shares | 43.50 |
Vested (in dollars per share) | $ / shares | 38.14 |
Forfeited (in dollars per share) | $ / shares | 36.11 |
Outstanding at end of period (in dollars per share) | $ / shares | $ 38.85 |
Stock-Based Compensation - Narr
Stock-Based Compensation - Narrative (Details) - USD ($) $ in Millions | 1 Months Ended | 3 Months Ended | |
Feb. 28, 2021 | Mar. 31, 2021 | Mar. 31, 2020 | |
Stock-based compensation | |||
Shares tendered by employees to pay employee withholding taxes (in shares) | 122,033 | ||
Nonvested Shares, Share Units Or DEU | |||
Stock-based compensation | |||
Total fair value of shares vested | $ 16 | $ 17.8 | |
Nonvested Shares, Share Units | |||
Stock-based compensation | |||
Total unrecognized compensation expense | $ 35.1 | ||
Expected weighted average period for recognition of expense | 2 years 1 month 6 days | ||
Performance Shares | Certain members of senior management | |||
Stock-based compensation | |||
Total unrecognized compensation expense | $ 4 | ||
Expected weighted average period for recognition of expense | 1 year 7 months 6 days | ||
Time-Based | Share Units | Employee | Incentive Program Bonus Award Fiscal Year Performance | |||
Stock-based compensation | |||
Award vesting period | 3 years | ||
Time-Based | Share Units | Employee | First Vesting Period | Incentive Program Bonus Award Fiscal Year Performance | |||
Stock-based compensation | |||
Vesting (as a percent) | 33.33% | ||
Time-Based | Share Units | Employee | Second Vesting Period | Incentive Program Bonus Award Fiscal Year Performance | |||
Stock-based compensation | |||
Vesting (as a percent) | 33.33% | ||
Time-Based | Share Units | Employee | Third Vesting Period | Incentive Program Bonus Award Fiscal Year Performance | |||
Stock-based compensation | |||
Vesting (as a percent) | 33.33% | ||
2013 Plan | Time-Based | Nonvested shares | Certain members of senior management | |||
Stock-based compensation | |||
Performance period | 3 years | ||
2013 Plan | Time-Based | Nonvested shares | Certain members of senior management | First Vesting Period | |||
Stock-based compensation | |||
Vesting (as a percent) | 33.33% | ||
2013 Plan | Time-Based | Nonvested shares | Certain members of senior management | Second Vesting Period | |||
Stock-based compensation | |||
Vesting (as a percent) | 33.33% | ||
2013 Plan | Time-Based | Nonvested shares | Certain members of senior management | Third Vesting Period | |||
Stock-based compensation | |||
Vesting (as a percent) | 33.33% | ||
2013 Plan | Performance -Based | Nonvested shares | Certain members of senior management | |||
Stock-based compensation | |||
Performance period | 3 years | ||
2013 Plan | Performance -Based | Nonvested shares | Certain members of senior management | Maximum | |||
Stock-based compensation | |||
Vesting percent | 200.00% |
Stock-Based Compensation - Su_2
Stock-Based Compensation - Summary of Nonvested Performance-based Share Awards (Details) - Nonvested shares | 3 Months Ended |
Mar. 31, 2021 | |
14% "Target" | |
Stock-based compensation | |
Three-Year Book Value Per Share CAGR | 14.00% |
14% "Target" | ≤25th percentile | |
Stock-based compensation | |
Vesting percentile | 100.00% |
14% "Target" | 50th percentile "Target" | |
Stock-based compensation | |
Vesting percentile | 150.00% |
14% "Target" | ≥75th percentile | |
Stock-based compensation | |
Vesting percentile | 200.00% |
12% | |
Stock-based compensation | |
Three-Year Book Value Per Share CAGR | 12.00% |
12% | ≤25th percentile | |
Stock-based compensation | |
Vesting percentile | 75.00% |
12% | 50th percentile "Target" | |
Stock-based compensation | |
Vesting percentile | 125.00% |
12% | ≥75th percentile | |
Stock-based compensation | |
Vesting percentile | 175.00% |
10% | |
Stock-based compensation | |
Three-Year Book Value Per Share CAGR | 10.00% |
10% | ≤25th percentile | |
Stock-based compensation | |
Vesting percentile | 50.00% |
10% | 50th percentile "Target" | |
Stock-based compensation | |
Vesting percentile | 100.00% |
10% | ≥75th percentile | |
Stock-based compensation | |
Vesting percentile | 150.00% |
8% | |
Stock-based compensation | |
Three-Year Book Value Per Share CAGR | 8.00% |
8% | ≤25th percentile | |
Stock-based compensation | |
Vesting percentile | 25.00% |
8% | 50th percentile "Target" | |
Stock-based compensation | |
Vesting percentile | 75.00% |
8% | ≥75th percentile | |
Stock-based compensation | |
Vesting percentile | 125.00% |
6% | |
Stock-based compensation | |
Three-Year Book Value Per Share CAGR | 6.00% |
6% | ≤25th percentile | |
Stock-based compensation | |
Vesting percentile | 0.00% |
6% | 50th percentile "Target" | |
Stock-based compensation | |
Vesting percentile | 50.00% |
6% | ≥75th percentile | |
Stock-based compensation | |
Vesting percentile | 100.00% |
Stock-Based Compensation - Su_3
Stock-Based Compensation - Summary of Compensation Expense, Net of Forfeitures (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2020 | |
Share-based Payment Arrangement [Abstract] | ||
Compensation expense | $ 5,179 | $ 4,780 |
Income tax benefit | $ 986 | $ 918 |
Dividend Restrictions (Details)
Dividend Restrictions (Details) - USD ($) $ in Thousands | May 05, 2021 | Mar. 31, 2021 | Dec. 31, 2020 | Mar. 31, 2020 |
Dividends Restrictions | ||||
Stockholders' equity | $ 3,920,937 | $ 3,862,633 | $ 3,107,074 | |
Essent Guaranty | ||||
Dividends Restrictions | ||||
Unassigned surplus | 385,900 | |||
Essent Guaranty | Principal Owner | Essent Holdings | Subsequent event | ||||
Dividends Restrictions | ||||
Dividends | $ 100,000 | |||
Essent PA | ||||
Dividends Restrictions | ||||
Unassigned surplus | 16,000 | |||
Essent Re | ||||
Dividends Restrictions | ||||
Stockholders' equity | 1,100,000 | |||
Essent Re | Essent Guaranty | Quota share reinsurance | Minimum | ||||
Dividends Restrictions | ||||
Stockholders' equity | $ 100,000 |
Earnings per Share (EPS) - Reco
Earnings per Share (EPS) - Reconciliation of Net Income and Weighted Average Common Shares Outstanding (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 3 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2020 | |
Earnings Per Share [Abstract] | ||
Net income | $ 135,648 | $ 149,523 |
Basic weighted average shares outstanding (in shares) | 112,016 | 97,949 |
Dilutive effect of nonvested shares (in shares) | 362 | 377 |
Diluted weighted average shares outstanding (in shares) | 112,378 | 98,326 |
Basic earnings per share (in dollars per share) | $ 1.21 | $ 1.53 |
Diluted earnings per share (in dollars per share) | $ 1.21 | $ 1.52 |
Earnings per Share (EPS) - Narr
Earnings per Share (EPS) - Narrative (Details) - shares | 3 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2020 | |
Earnings Per Share [Abstract] | ||
Antidilutive nonvested shares (in shares) | 352,623 | 353,230 |
2021 Performance based share awards | ||
EPS calculation | ||
Vesting percent | 100.00% | |
Percentage of award issuable if current period end were end of contingency period | 50.00% | |
Performance Shares | ||
EPS calculation | ||
Percentage of award issuable if current period end were end of contingency period | 100.00% |
Accumulated Other Comprehensi_3
Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2020 | |
Other comprehensive income (loss): | ||
Other comprehensive income, before tax | $ (69,404) | $ (17,053) |
Other comprehensive income (loss): | ||
Other comprehensive income, tax effect | 10,201 | 6,979 |
Net of Tax | ||
Stockholders equity, beginning of period | 3,862,633 | |
Other comprehensive income (loss): | ||
Total other comprehensive loss | (59,203) | (10,074) |
Stockholders equity, end of period | 3,920,937 | 3,107,074 |
Accumulated Other Comprehensive Income (Loss) | ||
Before Tax | ||
AOCI before tax, beginning of period | 168,324 | 69,401 |
Other comprehensive income (loss): | ||
AOCI before tax, end of period | 98,920 | 52,348 |
Tax Effect | ||
AOCI tax effect, beginning of period | (30,050) | (13,214) |
Other comprehensive income (loss): | ||
AOCI tax effect, end of period | (19,849) | (6,235) |
Net of Tax | ||
Stockholders equity, beginning of period | 138,274 | 56,187 |
Other comprehensive income (loss): | ||
Total other comprehensive loss | (59,203) | (10,074) |
Stockholders equity, end of period | 79,071 | 46,113 |
Accumulated Net Investment Gains (Losses) On Investments | ||
Other comprehensive income (loss): | ||
Unrealized holding gains arising during the period, before tax | (68,763) | (13,918) |
Less: Reclassification adjustment for gains included in net income, before tax | (641) | (3,135) |
Other comprehensive income, before tax | (69,404) | (17,053) |
Other comprehensive income (loss): | ||
Unrealized holding gains arising during the period, tax effect | 10,201 | 6,403 |
Less: Reclassification adjustment for gains included in net income, tax effect | 0 | 576 |
Other comprehensive income, tax effect | 10,201 | 6,979 |
Other comprehensive income (loss): | ||
Unrealized holding gains arising during the period, net of tax | (58,562) | (7,515) |
Less: Reclassification adjustment for gains included in net income, net of tax | (641) | (2,559) |
Total other comprehensive loss | $ (59,203) | $ (10,074) |
Fair Value of Financial Instr_3
Fair Value of Financial Instruments (Details) - USD ($) $ in Thousands | Mar. 31, 2021 | Dec. 31, 2020 |
Financial Assets: | ||
Fair Value | $ 4,701,476 | $ 4,565,373 |
Recurring | ||
Financial Assets: | ||
Total assets at fair value | 4,701,476 | 4,565,373 |
Recurring | U.S. Treasury securities | ||
Financial Assets: | ||
Fair Value | 262,309 | 268,444 |
Recurring | U.S. agency securities | ||
Financial Assets: | ||
Fair Value | 16,138 | 18,085 |
Recurring | U.S. agency mortgage-backed securities | ||
Financial Assets: | ||
Fair Value | 1,022,991 | 995,905 |
Recurring | Municipal debt securities | ||
Financial Assets: | ||
Fair Value | 572,263 | 551,517 |
Recurring | Non-U.S. government securities: | ||
Financial Assets: | ||
Fair Value | 79,280 | 61,607 |
Recurring | Corporate debt securities | ||
Financial Assets: | ||
Fair Value | 1,414,938 | 1,126,512 |
Recurring | Residential and commercial mortgage securities | ||
Financial Assets: | ||
Fair Value | 446,208 | 409,282 |
Recurring | Asset-backed securities | ||
Financial Assets: | ||
Fair Value | 473,804 | 454,717 |
Recurring | Money market funds | ||
Financial Assets: | ||
Fair Value | 413,545 | 679,304 |
Recurring | Quoted Prices in Active Markets for Identical Instruments (Level 1) | ||
Financial Assets: | ||
Total assets at fair value | 675,854 | 947,748 |
Recurring | Quoted Prices in Active Markets for Identical Instruments (Level 1) | U.S. Treasury securities | ||
Financial Assets: | ||
Fair Value | 262,309 | 268,444 |
Recurring | Quoted Prices in Active Markets for Identical Instruments (Level 1) | U.S. agency securities | ||
Financial Assets: | ||
Fair Value | 0 | 0 |
Recurring | Quoted Prices in Active Markets for Identical Instruments (Level 1) | U.S. agency mortgage-backed securities | ||
Financial Assets: | ||
Fair Value | 0 | 0 |
Recurring | Quoted Prices in Active Markets for Identical Instruments (Level 1) | Municipal debt securities | ||
Financial Assets: | ||
Fair Value | 0 | 0 |
Recurring | Quoted Prices in Active Markets for Identical Instruments (Level 1) | Non-U.S. government securities: | ||
Financial Assets: | ||
Fair Value | 0 | 0 |
Recurring | Quoted Prices in Active Markets for Identical Instruments (Level 1) | Corporate debt securities | ||
Financial Assets: | ||
Fair Value | 0 | 0 |
Recurring | Quoted Prices in Active Markets for Identical Instruments (Level 1) | Residential and commercial mortgage securities | ||
Financial Assets: | ||
Fair Value | 0 | 0 |
Recurring | Quoted Prices in Active Markets for Identical Instruments (Level 1) | Asset-backed securities | ||
Financial Assets: | ||
Fair Value | 0 | 0 |
Recurring | Quoted Prices in Active Markets for Identical Instruments (Level 1) | Money market funds | ||
Financial Assets: | ||
Fair Value | 413,545 | 679,304 |
Recurring | Significant Other Observable Inputs (Level 2) | ||
Financial Assets: | ||
Total assets at fair value | 4,025,622 | 3,617,625 |
Recurring | Significant Other Observable Inputs (Level 2) | U.S. Treasury securities | ||
Financial Assets: | ||
Fair Value | 0 | 0 |
Recurring | Significant Other Observable Inputs (Level 2) | U.S. agency securities | ||
Financial Assets: | ||
Fair Value | 16,138 | 18,085 |
Recurring | Significant Other Observable Inputs (Level 2) | U.S. agency mortgage-backed securities | ||
Financial Assets: | ||
Fair Value | 1,022,991 | 995,905 |
Recurring | Significant Other Observable Inputs (Level 2) | Municipal debt securities | ||
Financial Assets: | ||
Fair Value | 572,263 | 551,517 |
Recurring | Significant Other Observable Inputs (Level 2) | Non-U.S. government securities: | ||
Financial Assets: | ||
Fair Value | 79,280 | 61,607 |
Recurring | Significant Other Observable Inputs (Level 2) | Corporate debt securities | ||
Financial Assets: | ||
Fair Value | 1,414,938 | 1,126,512 |
Recurring | Significant Other Observable Inputs (Level 2) | Residential and commercial mortgage securities | ||
Financial Assets: | ||
Fair Value | 446,208 | 409,282 |
Recurring | Significant Other Observable Inputs (Level 2) | Asset-backed securities | ||
Financial Assets: | ||
Fair Value | 473,804 | 454,717 |
Recurring | Significant Other Observable Inputs (Level 2) | Money market funds | ||
Financial Assets: | ||
Fair Value | 0 | 0 |
Recurring | Significant Unobservable Inputs (Level 3) | ||
Financial Assets: | ||
Total assets at fair value | 0 | 0 |
Recurring | Significant Unobservable Inputs (Level 3) | U.S. Treasury securities | ||
Financial Assets: | ||
Fair Value | 0 | 0 |
Recurring | Significant Unobservable Inputs (Level 3) | U.S. agency securities | ||
Financial Assets: | ||
Fair Value | 0 | 0 |
Recurring | Significant Unobservable Inputs (Level 3) | U.S. agency mortgage-backed securities | ||
Financial Assets: | ||
Fair Value | 0 | 0 |
Recurring | Significant Unobservable Inputs (Level 3) | Municipal debt securities | ||
Financial Assets: | ||
Fair Value | 0 | 0 |
Recurring | Significant Unobservable Inputs (Level 3) | Non-U.S. government securities: | ||
Financial Assets: | ||
Fair Value | 0 | 0 |
Recurring | Significant Unobservable Inputs (Level 3) | Corporate debt securities | ||
Financial Assets: | ||
Fair Value | 0 | 0 |
Recurring | Significant Unobservable Inputs (Level 3) | Residential and commercial mortgage securities | ||
Financial Assets: | ||
Fair Value | 0 | 0 |
Recurring | Significant Unobservable Inputs (Level 3) | Asset-backed securities | ||
Financial Assets: | ||
Fair Value | 0 | 0 |
Recurring | Significant Unobservable Inputs (Level 3) | Money market funds | ||
Financial Assets: | ||
Fair Value | $ 0 | $ 0 |
Statutory Accounting - Schedule
Statutory Accounting - Schedule of Statutory Net Income, Statutory Surplus and Contingency Reserve Liability (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2020 | |
Essent Guaranty | ||
Dividends Restrictions | ||
Statutory net income | $ 112,401 | $ 122,644 |
Statutory surplus | 1,091,217 | 1,074,153 |
Contingency reserve liability | 1,575,323 | 1,270,864 |
Essent PA | ||
Dividends Restrictions | ||
Statutory net income | 1,129 | 1,627 |
Statutory surplus | 54,964 | 53,648 |
Contingency reserve liability | $ 56,535 | $ 53,854 |
Statutory Accounting - Narrativ
Statutory Accounting - Narrative (Details) - USD ($) $ in Thousands | 3 Months Ended | ||
Mar. 31, 2021 | Mar. 31, 2020 | Dec. 31, 2020 | |
Essent Guaranty | |||
Dividends Restrictions | |||
Increase in contingency reserve | $ 75,500 | ||
Released contingency reserve | 600 | ||
Statutory net income | 112,401 | $ 122,644 | |
Essent PA | |||
Dividends Restrictions | |||
Increase in contingency reserve | 500 | ||
Released contingency reserve | 100 | ||
Statutory net income | 1,129 | 1,627 | |
Essent Re | |||
Dividends Restrictions | |||
Statutory capital and surplus | 1,100,000 | $ 1,100,000 | |
Statutory net income | $ 48,400 | $ 49,500 |